Contents:

1. Key Facts

2. Business Overview

3. Management & Ownership

4. Industry Overview

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

   ---

1. Key Facts

Description: Grab Holdings is the leading Superapp in Southeast Asia, providing a suite of everyday services including Ride-Hailing (Mobility), Food & Grocery Delivery (Deliveries), and Financial Services (Payments, Lending, Digital Banking). It operates across 8 countries, including Malaysia, Indonesia, Vietnam, Singapore, and Thailand.

Key Financials: Grab made its IPO on the Nasdaq in late 2021. From FY20 to trailing twelve months (TTM) ended Q3’25, Grab achieved a revenue Compound Annual Growth Rate (CAGR) of 50%, generating TTM revenue of $3.2 billion. Grab has reached a profitability inflection point after years of investment. Over the same period, the Company improved its operating income from a loss of $1.3 billion to a profit of $26 million. Grab has cash and short-term investments of $7.1 billion and total debt of $2.1 billion.

Price & Market Cap (as of 2 January 2026): Its market cap is $21 billion with a 52-week low of $3.36 and a 52-week high of $6.62, whereas it currently trades at $5.08.

Valuation: Grab trades at a LTM EV/Sales of 5x (4 Year average of 9x).

Subscribe now

2. Business Overview

a. Fixing a Broken Industry

Grab traces its roots to 2011, originating from a business plan devised by Harvard Business School classmates Anthony Tan and Tan Hooi Ling. Their objective was to revolutionize the Malaysian taxi industry by using technology to solve deep-seated issues of safety, reliability, and efficiency. At the time, the market was plagued by overcharging, frequent ride refusals, and significant safety risks, particularly for women. With their vision to connect passengers to licensed drivers validated by a runner-up finish and a $25,000 grant at the 2011 HBS New Venture Competition, the groundwork for Grab was officially established.

b. Boots on the Ground

The app officially launched in June 2012 in Kuala Lumpur under the name MyTeksi. The launch was initially financed through personal funds. Despite his family’s significant wealth, Anthony Tan’s father rejected the concept, urging him to remain in the traditional family business. Undeterred, Anthony funded the initial operations using the $25,000 prize money from Harvard and his personal savings, while his mother stepped in as Grab’s first individual angel investor.

Anthony relocated to Kuala Lumpur to lead operations. The app’s debut was met with overwhelming demand, reportedly receiving 11,000 booking requests on its first day. This immediate traction highlighted a critical bottleneck: supply. The team had to recruit as many drivers as they could to meet demand.

However, in 2012, this was easier said than done. The barrier to entry was high as most taxi drivers did not own smartphones and the concept was relatively new. The founding team adopted an intensely hands-on approach to bridge this gap. They visited airports, gas stations, and coffee shops to personally recruit drivers, often having to convince them of the value of mobile technology. The company went as far as purchasing smartphones in bulk and reselling them to drivers on installment plans, effectively subsidizing their fleet’s digitization.

These ground game tactics proved so effective that they became the blueprint for regional expansion.

“In Vietnam, we approached drivers at 4 a.m. at the start of their shifts,” described Aaron Gill, an early executive. “In Singapore, we targeted taxi queues at Changi Airport. One person would explain the app to the driver, and the other would download it onto his phone.”

The value proposition was compelling: the app allowed drivers to optimize their routes, earning more while spending less time idling. With the incentives aligned, the supply network began to scale rapidly. By May 2013, data from early investor Vertex Ventures showed that Grab had successfully onboarded approximately 2,000 drivers and was processing 96,386 unique bookings per month.

Source: Vertex Ventures

Subscribe now

c. Expansion and the Defeat of Uber

Following its Malaysian debut in 2012, Grab expanded into the Philippines, Singapore, and Thailand in 2013, followed by Vietnam and Indonesia in 2014. This expansion was fueled by its first major institutional backing in 2014 from Vertex Ventures, at a time when the app had approximately 250,000 monthly active users.

Growth coincided with the 2013 arrival of Uber. Despite Uber’s deep pockets and superior tech, they failed to dominate, leading to a five-year battle for the region. Grab’s eventual victory was rooted in hyper-localization. While Uber tried to replicate its US model, Grab adapted to the nuances of Southeast Asia.

• Cash Adoption: Realizing that credit card penetration was low, Grab accepted cash payments from Day 1—a feature Uber was slow to adopt, effectively locking itself out of the mass market.

• Beating Traffic: In congested cities like Ho Chi Minh City, Grab launched GrabBike (motorcycle taxis), a culturally attuned solution that allowed passengers to weave through traffic.

• Regulatory Strategy: Unlike Uber’s infamous “move fast and break things” approach, Grab positioned itself as a partner to governments, working collaboratively to solve traffic and safety issues.

As noted by early investor Vertex Ventures:

“Uber worked on the principle of ‘anti-regulator’ while Grab has always worked with regulators. In SEA, the ‘anti-regulator’ approach does not work. Perhaps the key factor... lies in the company’s management – where the Founders lead and run the business. Competitors like Uber were managed by hired professionals with no Founders’ mentality.”

In March 2018, the battle ended in a historic consolidation. Uber surrendered, selling its entire Southeast Asian operations to Grab in exchange for a 27.5% equity stake, with CEO Dara Khosrowshahi joining Grab’s board. This victory cemented Grab’s uncontested leadership in the region.

Subscribe now

d. The Superapp Pivot

With Uber’s exit, Grab pivoted from a ride-hailing app to a comprehensive “Superapp” ecosystem. The acquisition of Uber’s assets allowed Grab to immediately scale GrabFood, leveraging its massive driver fleet to deliver meals.

Simultaneously, the Company moved to capture the region’s massive underbanked population. GrabPay, originally introduced in 2016 as an in-app payment method, was relaunched in November 2017 as a full-fledged digital wallet for third-party merchants. This fintech ambition culminated in Grab securing digital banking licenses in Singapore and Malaysia, giving Grab the opportunity to become a digital financial services powerhouse.

This evolution transformed Grab from a utility app into a synergistic ecosystem. By stacking high-frequency services like Mobility and Delivery atop a financial layer, Grab created a self-reinforcing flywheel. Today, the platform functions as a walled garden where users acquired through daily commutes or lunch orders are naturally funneled into higher-value services like payments, lending, and insurance.

Source: Grab Investor Day 2022

e. The IPO, The Crash, and The Pivot

In December 2021, Grab went public on the Nasdaq via a merger with Altimeter Growth Corp, the largest SPAC deal in history, valuing the company at nearly $40 billion. However, the post-listing experience has been a volatile ride for shareholders, with the stock currently down approximately 57% from its IPO price.

Priced for perfection at the peak of the 2021 SPAC bubble, the valuation left no margin for error. At $40 billion, Grab was trading at over 20x revenue while simultaneously burning roughly $1 billion in cash annually. Inevitably, reality failed to meet these heightened expectations.

The most painful reality check occurred in March 2022, when Grab released its Q4’21 earnings—its first major report as a public company. Revenue collapsed 44% YoY to just $122 million (missing analyst expectations of ~$167 million). The cause was the aggressive growth strategy: Grab had poured massive amounts into driver and rider incentives to defend its market share. Because Grab reports revenue net of these incentives, this spending effectively wiped out its top line, shocking investors who had focused on top-line growth.

It is only recently (late 2024/2025) that the stock has begun to stabilize. This shift has been driven by a decisive change in management’s tone from growth at all costs to sustainable profit. The promise fulfilled by delivering the firstGAAP profitablele quarter in Q3’25.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

f. Geographic Footprint

Grab has built a diversified revenue base with the platform’s reach spanning to over 800 cities across eight countries in Southeast Asia. As of FY24, Malaysia stands as the largest revenue contributor at $816 million (29% of total revenue), followed by Indonesia at $643 million (23%), and Singapore at $578 million (21%).

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

g. GMV, Take Rates and Incentives

The adoption of the platform is best measured by Gross Merchandise Value (GMV)—the total amount users spend on mobility and deliveries. This metric has demonstrated robust growth, expanding from $14 billion in FY22 to $21 billion over the last twelve months, representing a 16% CAGR.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

However, the critical lever for investors is the Take Rate which is the percentage of GMV or the commission that Grab retains as revenue. Grab currently reports a take rate of approximately 14%, but this figure is net of the incentives paid to consumers (discounts) and partners (driver bonuses). Historically, these incentives were aggressive, often exceeding the commissions earned to stimulate supply in rural areas or during market launches. As recently as FY22 and FY23, Grab reported “excess incentives” of $580 million and $391 million respectively, meaning they paid out more than they earned in specific segments.

As the marketplace matures, management is rationalizing this spend, turning a former headwind into a tailwind. Over the last three years, Grab’s net take rate averaged 14% while incentives consumed roughly 10% of GMV. By comparison, Uber reports a take rate closer to 27%. This spread highlights the massive latent profitability in Grab’s model. In a rationalized monopoly/duopoly environment, if Grab can structurally reduce incentives by just 3 percentage points, nearly all of that savings would flow directly to the bottom line as incremental profit.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers) *Post FY23 Grab made reporting changes to its On-Demand GMV

h. User Base and Monetization Trends

Grab’s user base continues to expand, reaching 48 million Monthly Transacting Users (MTUs) as of the end of 2024, a 16% CAGR since 2021. Despite this scale, the runway remains long; 48 million users represent only roughly 10% of the working-age population in its operating regions. In a market consolidating around 2-3 key players—similar to the US (Uber, Lyft, DoorDash) or Europe (Uber, Bolt, Wolt)—Grab’s leadership position allows it to capture the majority of this remaining penetration.

Notably, growth is accelerating, with MTUs up 14% YoY in Q3 ’25, and Daily Transacting Users growing even faster than the monthly metric.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

Breaking this down by segment as of the end of FY24, Financial Services leads with 26.4 million MTUs (+13% YoY), followed by Mobility at 25.3 million (+24% YoY) and Deliveries at 21.7 million (+14% YoY).

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

Alongside user growth, the monetization per user is reaching an inflection point. While GMV per MTU saw a strategic decline in 2024 (dropping 2% to $494), this was a calculated trade-off to drive mass-market adoption through affordable options like "GrabCar Saver" and "GrabFood Saver." This strategy is now bearing fruit. In Q3 ’25, Grab recorded its second consecutive quarter of rising wallet share, with GMV per MTU growing 7% YoY, proving that the new affordable cohorts are increasing their transaction frequency and graduating into the broader ecosystem.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

Read more

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

Subscribe now

1. Key Facts

Description: Hubspot is a leading Customer Relationship Management (CRM) and marketing automation platform, designed primarily for small and mid-size companies (SMBs). The company has expanded into a comprehensive, multi-product suite of “Hubs” (including Marketing, Sales, Service, Content, and Commerce). This integrated platform allows customers to consolidate their entire go-to-market tech stack, providing a unified view of the customer journey, which is now being enhanced with a deep layer of AI features.

Key Financials: From FY15 to trailing twelve months (TTM) Q2’25, HubSpot achieved a revenue Compound Annual Growth Rate (CAGR) of 34%, reaching TTM revenue of $2.8 billion. While not yet GAAP profitable, HubSpot has expanded its non-GAAP operating income from a $25.1 million loss in 2014 to an LTM non-GAAP operating profit of $488 million (17.1% operating margin). The company has cash and short-term investments of $1.7 billion, zero debt, and operating lease liabilities of $281 million.

Price & Market Cap (as of 31 October 2025): Its market cap is $25.9 billion with a 52-week low of $418 and a 52-week high of $881, whereas it currently trades at $492.

Valuation: Hubspot trades at a LTM EV/Sales of 8.6x (5 Year average of 16.1x).

2. Business Overview

a. The ‘Inbound’ Philosophy

HubSpot’s entire existence stems from a fundamental shift in marketing philosophy, championed by its founders, Brian Halligan and Dharmesh Shah, during their time as graduate students at MIT in the mid-2000s. They observed that traditional “outbound” marketing tactics like cold calls, spam emails, and broadcast ads were becoming increasingly ineffective. They were interrupting customers instead of attracting them.

Halligan and Shah realized that businesses needed to adapt to this new reality. Their core insight, which they detailed in their best-selling book “Inbound Marketing: Get Found Using Google, Social Media and Blogs”, was to flip the traditional marketing model. Instead of pushing messages out to uninterested audiences, businesses should pull customers in by creating valuable content and experiences tailored to them.

This became the “Inbound Marketing” philosophy. The concept is straightforward: stop chasing customers and help them find you. The strategy involves publishing useful content (such as blog posts, e-books, videos) optimized for search engines (SEO) and shared via social media and email. This content naturally attracts individuals already searching for solutions online, allowing businesses to build trust and credibility, ultimately converting interested strangers into loyal customers.

When HubSpot was founded in 2006, this philosophy was its entire focus. The company’s original software was designed as an all-in-one platform to empower businesses, particularly small and medium-sized ones, to execute this inbound strategy effectively.

Join +7,850 investors

b. The HubSpot Platform: From Marketing Tool to AI CRM

The original Hubspot platform integrated tools for social media, SEO, blogging, website content management, marketing automation, email, and analytics, solving the pain point of businesses needing multiple applications for these tasks.

The founders specifically targeted SMBs, a segment largely ignored by competitors who focused on upmarket clients. As the founders discussed in their ‘Crucible Moments’ interview with Sequoia Capital, they believed the internet leveled the playing field for SMBs and that inbound marketing offered a cost-effective way for these businesses (often lacking large budgets) to gain traction online.

“You used to need a ton of money to get found online, but all of a sudden, there was Google and social. And if you create a great piece of content, it would spread and pull people in like a magnet. Now, all of a sudden, any small business could create content and your success in marketing shifted and your success became much more about the width of your brain than the width of your wallet.” Brian Halligan

“But trying to put all the pieces together to kind of leverage the internet in the way that it needed to be leveraged and to do inbound marketing, it just was a science project for a lot of these companies. They did not have the time or the talent to actually do all those things.” Dharmesh Shah

While investors initially balked at the SMB focus due to perceived high acquisition costs and churn rate, Halligan and Shah argued that the efficiency of inbound marketing negated this concern.

“Everyone’s reaction to SMB was consistent. Don’t do it. No one liked the idea of doing a small business play.” Brian Halligan

The CRM Launch: The Trojan Horse

Source: Hubspot Q2’25 Earnings presentation

The next pivotal moment arrived in 2014, coinciding with the company’s IPO. Recognizing that the owner of the CRM often wins the customer relationship, HubSpot introduced its free CRM product.

They realized that the sales process was outdated, and the CRM available at the time was complex and affordable only to big customers. SMBs were still using spreadsheets, email and memory to manage their customer relationships. And the CRM, was not given only to existing customers, it was given out for free.

The two main barriers keeping SMBs from using a CRM were that existing products were too complicated or too expensive. HubSpot aimed to remove both of these.

This aligned perfectly with the company’s core mission “Help millions of organizations grow better” as former Chief Strategy Officer Brad Coffey explained in a 2015 blog post detailing the decision:

“From a culture perspective, giving the CRM away for free wasn’t a crazy idea. Our overarching mission is to solve for the customer and the entire inbound movement is rooted in the idea that the size of your brain matters more than the size of your wallet. We didn’t want a product that would only be valuable to our existing marketing customers or to companies with big budgets; we wanted one that would empower any business to grow. The simplest way to remove any barriers to smarter prospecting was to make the CRM free to everyone. Growing the number of visitors, leads, and customers is a goal shared by thousands of companies HubSpot reaches every day. But many of them don’t use the core, modern tools to engage with those prospects effectively. These companies are relying on email, spreadsheets and their memory to move their deals through the sales process. They simply don’t have a CRM -- and they should. We found that cost and complexity were the big inhibitors of adoption.”

Now, Hubspot was going head-to-head with the elephant in the room, Salesforce, a Company synonymous to CRM.

But this freemium CRM became the “Trojan horse”, attracting a massive user base and dramatically lowering customer acquisition costs. It established the central, unified database for customer information. From this foundation, HubSpot systematically expanded its offerings, adding specialized, paid “Hubs” that were integrated into the free CRM.

The Hubs: A Multi-Product Suite

Source: Investor Day 2025 Presentation

Today, the HubSpot platform consists of several integrated Hubs built around the core CRM:

1. Marketing Hub: The original inbound marketing suite. It surpassed $1.5B in ARR as of Q2’25 (up 11% year-over-year) and recognized as a leader by Gartner for fifth consecutive year. It is the largest hub in terms of ARR, being approximately 50% of Hubspot’s total ARR ($2.9 billion as of the end of 2024). The hub provides a comprehensive toolset which includes features for lead generation (forms, landing pages), content creation (blogging, video hosting), and marketing automation. It also integrates email marketing, social media management, SEO tools, and performance-based advertising analytics.

2. Sales Hub: Introduced alongside the CRM in 2014, it is the second largest hub, providing tools for deal pipeline management, quoting, forecasting, meeting scheduling and more. It has seen rapid growth, up 24% year-over-year as of Q2’25, and cited as $500 million plus business in Q1’23.

3. Service Hub: Launched in 2018, with tools for ticketing and support. Service Hub growth is sustained in the high 20s.

4. Content Hub: Initially part of the Marketing Hub , it was unbundled and launched as a standalone CMS product in 2020 and rebranded/relaunched with significant AI capabilities in 2024. It is the fastest growing hub, and saw significant increase in attached rates to marketing hub, increasing to 54% in Q4’24 compared to 13% in prior year.

5. Operations Hub (now Data Hub): Launched in April 2021 to help sync customer data and automate processes.

6. Commerce Hub: Launched in 2023, this is a key feature that enables customers to accept payments to facilitate quoting, billing, and payment collection directly within the CRM. As of October 2024, and since launched in 2023, HubSpot has processed more than $1 billion in GMV. This is relatively small but payments have ample room of opportunity to grow.

This multi-hub strategy allows customers to consolidate their go-to-market tech stack on a single platform, reducing complexity and providing a unified view of the customer journey, a significant value proposition in today’s fragmented software landscape.

Integral to the platform’s value is its openness. HubSpot boasts a robust App Ecosystem with over 1,900 integrations (more than 10x over the last five years) of third-party apps. Customer usage is high, with the average number of active integrations per customer growing from 10 to 14 over the last 5 years. This ecosystem approach increases stickiness and embeds HubSpot into customer workflows. HubSpot views its unified data platform as a key differentiator in realizing value from AI faster than competitors, as AI thrives on the complete customer context provided by having marketing, sales, and service data in one place.

c. The Go-to-Market Strategy

HubSpot’s go-to-market strategy is to acquire customers across the entire business spectrum, from individuals to large enterprises. Its freemium-based pricing model acts as the flywheel for the entire system, designed to make it easy for customers to try, buy, and grow with the platform. This results in a scalable model. As small businesses grow, their needs become more complex, and they naturally upgrade to the higher-priced Pro and Enterprise tiers, becoming high-value customers.

The overall approach is “bimodal,” focusing on two distinct goals simultaneously:

1. Driving Volume: At the lower end (Free and Starter tiers).

2. Driving Value: At the higher end (Professional and Enterprise tiers)

The Bimodal “Flywheel”: Tiers

• Free and Starter Tier: This is the high-volume tier used to attract millions of small businesses. The Starter tier alone represents about half of all customers (up 10 percentage points over the last 4 years), though it contributes only a small percentage of revenue, as it typically serves single-seat businesses at a low price points (around $15/month).

Source: Investor Day 2025 Presentation

• Pro and Enterprise Tiers: While the Starter tier drives customer volume, the Professional and Enterprise tiers drive the vast majority of revenue. This is a targeted, high-touch approach for larger, more complex businesses.

Join +7,850 investors

The 2024 Pricing Overhaul

In an effort to reduce friction, accelerate customer acquisition, and encourage upgrades, HubSpot initiated a significant pricing strategy adjustment that took effect in March 2024.

The core problem was the jump from starter to pro, which customers consistently cited as a major point of friction. The legacy model included a high base fee plus a minimum number of paid seats (e.g., 5 for Pro) for its higher tiers. This created a significant entry cost.

The new model attacks this friction directly:

1. It lowered the price of the Starter tier to boost free-to-starter conversions.

2. It eliminated seat minimums from Pro tiers, allowing customers to start with exactly what they need and buy more as they grow.

As CEO Yamini Rangan noted, “by lowering the price per seat for pro and enterprise, it reduces that friction. And again, we’re seeing that. And in making this change, there are more customers that start with starter and then continue to upgrade into pro and enterprise, which is exactly what we want in order to be -- to have a great”

This change created an intentional trade-off: a lower Average Subscription Revenue Per Customer (ASRPC) in the short term, which is expected to be ultimately offset by higher customer volume. Early signs validate this thesis:

• Free-to-Starter conversion is at an all-time high, up 50% year-over-year.

• The average number of Pro Plus customers added quarterly increased by 16% post-launch.

• The share of customers who upgrade their Sales or Service seat is about 3 points higher under the new model.

• The change is expected to be a 2-point tailwind to Net Revenue Retention in 2025 and a continued benefit in 2026.

A critical component of the March 2024 pricing change was the introduction of the Core Seat. The rationale of this decision was to unbundle and monetize the Smart CRM platform itself, rather than giving it away through the purchased hubs.

• Legacy Model: Under the old model, only about 20% of users required a paid seat. These were “Persona Seats” for sales or service reps. The core CRM editing functions were often used for free by admins and operations.

• New Model: The Core Seat is now required for edit access to the Smart CRM, while free “View-Only” seats are unlimited. This move directly monetizes the admin and operations users who derive value from the platform. As a result, about 60% of users who purchase under the new model now take a paid seat.

This strategy has been validated quickly. In just 18 months, the Core Seat surpassed $100 million in ARR and is growing quickly, confirming the thesis that significant untapped value existed in the Smart CRM.

The Solutions Partner Ecosystem

A defining component of HubSpot’s strategy is its vast ecosystem of over 6,000 “Solutions Partners” (e.g., marketing agencies, sales consultants), which contributes approximately 40% of customer ARR. This channel is highly effective in acquiring larger, upmarket customers.

In late 2023, HubSpot announced a significant change to its commission structure (effective in 2025), shifting incentives from retention to acquisition. The legacy 20% lifetime commission was replaced by a 3-year commission on new deals, and lifetime commissions for existing deals are revoked if solution partners are not actively engaged with customers.

Despite this controversial change, the channel remains robust; co-selling (a key indicator of partner engagement) grew 41% year-over-year in Q1 2025, followed by 29% in Q2 2025. While the long-term effect on the partner ecosystem is still to be seen, we expect the new structure to drive profitability improvements for HubSpot in the future.

d. Customer Landscape

HubSpot’s customer base has evolved significantly from its early days, growing from 11,000 customers at its 2014 IPO to over 270,000 today. The company primarily targets small and mid-size companies, generally those with 2-2,000 employees, with its largest segment being the 20-200 employee cohort.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The business is also geographically diverse, with 39% of revenue coming from outside the US. Subscriptions are the dominant revenue source, accounting for 98% of revenue, with the remaining 2% from services like on-boarding, training, and Commerce Hub payments.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

Retention (NRR vs. CDR)

HubSpot tracks two key retention metrics that tell different stories:

• Customer Dollar Retention (CDR): This metric primarily reflects churn and has remained stable and healthy in the “high 80s” (88% as of 1H’25). This stability highlights the platform’s stickiness.

• Net Revenue Retention (NRR): This metric includes expansion from existing customers (upgrades and cross-selling). After tracking above its 110% long-term target, NRR fell post-Q2’22 to 102% by 2024. This decline was primarily driven by a slowdown in expansion motions as macroeconomic pressure (high inflation and interest rates) forced companies to optimize spend, reduce seats, and slow upgrades.

“The area where we continue to see challenge is the same one we’ve been talking about for a number of quarters, which is on that net upgrade rate… we’re also seeing lower volume of customers adding contacts and seats… customers… are really looking to optimize their spend across the board.” Kathryn Bueker, CFO Q2’23

To combat this, HubSpot enforced the pricing changes discussed in the previous section. As of Q2’25, NRR ticked up to 103% (102% in Q1’25), an improvement almost entirely driven by strong seat upgrade performance from the new model. While seat upgrades are strong, other expansion motions (like tier upgrades) are still lagging behind.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The Upmarket & Multi-Hub Trend

A core component of HubSpot’s strategy is moving “upmarket” by selling more products to larger customers, as multi-product customers have demonstrably better retention. The key indicator of this strategy’s success is multi-hub adoption, which shows a clear and sustained trend of customers consolidating their tech stack onto the HubSpot platform.

“New and existing customers are consolidating their go-to-market technology stack on HubSpot. … The share of our installed base ARR that has on a single hub is now just 12%, more than 60% of Pro Plus ARR is on 3 or more hubs and customer ARR on 5 or more hubs has grown from 0 to 28% in Q2.” Kathryn Bueker, CFO

ASRPC and Net New ARR Trends

The recent pricing changes have intentionally impacted the headline ASRPC metric, as the company is acquiring a high volume of lower-cost Starter tier customers. However, management highlighted in Q3’24 that ASRPC growth, excluding the Starter tier, was in the mid-single digits. After three consecutive quarters of decline, ASRPC increased 1% in Q2’25 and is expected to grow at that rate for the back half of the year.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

More importantly, Net New ARR growth, which hit a low point in 1H 2023, has seen momentum, a clear sign of revenue re-acceleration.

“As you can see, net new ARR was challenged beginning in 2022... and hit a low point in the first half of 2023. Over the last 2 years, we have seen building momentum and a nice step-up in net new ARR growth in the back half of 2024. Since then, net new ARR growth has outpaced revenue growth. We are executing well, and our growth is beginning to accelerate.”

Join +7,850 investors

e. AI Strategy: The Future

HubSpot is embedding AI across its entire platform, infusing it into all hubs and tiers to drive adoption and increase the value of its core products. The company’s monetization strategy is two-pronged: driving upgrades to Pro+ tiers, which include premium AI features, and capturing consumption-based revenue through additional credits.

As CEO Yamini Rangan highlighted in Q4 2023, the plan has been to use AI as a key driver for tier upgrades:

“While all of our tiers... have AI features, we have a lot more features at the pro and enterprise tiers. In fact, 65% of the features that are becoming generally available in the first half of 2024 will be in the pro+ tier. So the way we think about it is that it will drive a lot of upgrades... And then longer term, when we drive even more sophisticated features like AI agents, then we may charge specifically for it.”

HubSpot’s competitive advantage in the AI era is not the AI models themselves, but its unified data platform. The company’s thesis is that while LLMs know the public web and provide generalized insights, HubSpot has the specific customer context—both structured (residing within the CRM) and unstructured (calls, emails). This allows the AI to provide insights and value tailor-made to a specific customer’s data.

This AI initiative is consolidated under the “Breeze” platform and includes Breeze Copilot, which acts as AI-powered companion, embedded AI features across the hubs and AI Agents that execute tasks.

Embedded AI Features

These tools function as an assistant, designed to streamline tasks and provide data-driven recommendations. Key features include:

• Sales Hub: AI meeting assistant to streamline preparation and follow-up, deal intelligence and guided actions to recommend next steps.

• Service Hub: AI-powered ticket sentiment analysis, feedback summaries, and GPT-powered chatbots.

• Content Hub: A suite of AI tools for content creation, remixing, and maintaining a consistent brand voice.

Usage metrics for these features signal accelerating adoption. Copilot engagement more than doubled from 270,000 active users in Q4’24 to 660,000 in Q1’25. AI features in the Content Hub have significantly boosted its attach rate to the Marketing Hub, now at 50%. Meanwhile, more than 40% of Service Hub customers are already leveraging AI capabilities.

Source: Investor Day 2025 Presentation

Featured AI Agents

Featured AI agents are designed to do work on your behalf and even communicate with each other.

“They are the AI coworker that can now take on more jobs like support, prospecting, account research and then allows the rest of the teams to do high-value work. Now there are a whole universe of agents out there. So I want to try and simplify HubSpot’s approach to agents. We build featured agents for go-to market teams to get work done. Now our prospecting agent will do account research and outreach. The customer agent will help support tickets, but also answer questions across sale and marketing. And the newly launched data agent today, it enriches customers’ data with AI. Each of these agents will get work done, but they can also call on each other to do more for our customers. Then, we are providing the ability for our customers and partners to build custom agents.” Yamini Rangan

• Customer Agent: The agent focused on support. It is already used by over 5,000 customers (2,500 customers in Q1) and achieved a 65%+ resolution rate, having resolved over 1 million tickets. Customer agents close tickets 39% faster than non-users.

• Prospecting Agent: This agent watches for intent signals, researches prospects and send personalized outreach, saving time for reps. It has been used by over 3,700 customers and 17,000 are on waitlist.

• Content Agent: This agent helps create and personalize content. It has been used by over 12,000 customers to generate content over the last year.

The Agent Builder Ecosystem

Beyond providing its own featured agents, HubSpot is creating an ecosystem for others to build their own agents, pursuing a bimodal strategy to capture agent builders at both the high and low ends of the market.

• Breeze Studio (The Upmarket Solution): Launched in September 2025, Breeze Studio is an agent platform integrated directly within HubSpot. It is designed for HubSpot customers and partners to build and list custom AI agents on the Breeze Marketplace. This addresses the complex, higher-end agent needs of companies.

• Agent.ai (The “Citizen Builder” Network): At the other end of the spectrum, HubSpot is also developing Agent.ai, a low-code tool that operates as a network outside the core platform. It targets “citizen builders” solving simpler, specific tasks for themselves or small teams. This initiative has shown strong early traction, attracting over 2 million users who have built more than 46,000 agents.

Connecting to the frontier AI models

Instead of viewing frontier models as competition, HubSpot is integrating with them, turning a potential threat into a strategic partnership.

In Q2’25, the company has launched connectors for OpenAI’s ChatGPT, Anthropic’s Claude, and Google’s Gemini. The value proposition is simple: it allows a customer to ground a powerful, general-purpose LLM with their own private, specific CRM data.

This allows a user to ask ChatGPT: “find my highest-converting cohorts from recent contacts and create a tailored nurture sequence to boost engagement”. The AI can only provide that valuable, specific answer because the connector feeds it the context from the Smart CRM. The adoption has been high, as 20,000 customers have already used it to access insights across 23 million CRM records.

AI is also driving leverage within Hubspot

Beyond enhancing its customer-facing products, HubSpot is deploying AI internally as a key lever to drive operational leverage and scale its business.

As the company explained in its 2025 Analyst Day:

“our agent handled about half of our customer tickets in the first half of 2025. As a result, we have been able to hold support headcount flat for over 2 years. In marketing, we are heavy users of AI for content generation and personalization, and we have seen both efficiency gains and also higher conversion rates as a result of AI. And finally, we have started to deploy AI tools across our employee life cycle that we believe will allow us to continue to scale our best-in class G&A efficiency.” Kathryn Bueker, CFO

Join +7,850 investors

💭 You’ve seen HubSpot’s powerful strategic pivot from an inbound pioneer to an AI-first company. The product and the narrative are compelling.

But does the execution match the vision? And more importantly, what is it worth?

The rest of this deep dive is under paywall and addresses the following:

• Management: Does the leadership team have the right incentives and track record to navigate this complex shift?

• Industry: How does HubSpot really stack up against Salesforce and Adobe, and just how big is its total addressable market?

• Financials: We analyze the true cash flow, margin, and future outlook to see when this bet will actually pay off.

• Risks: We consider the risks of AI cannibalization and competition from the frontier AI models.

• Valuation: We run a full DCF model to determine our price target for the stock and whether it’s a buy.

To see our full analysis, valuation, and final conclusion, become a paid subscriber.

Read more

In this report, we break down its business model, analyze key industry trends, highlight its long-tenured management team, and conclude with our valuation.

Let’s dive in.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

Subscribe now

1. Key Facts

Description: INVISIO provides advanced communication and hearing protection systems for defense and public safety professionals. Its INVISIO and Racal Acoustics brands serve military forces, law enforcement, and security units that depend on reliable communication in mission-critical environments.

Key Financials: From fiscal year 2015 through the trailing twelve months (TTM) ending Q2 2025, Invisio has delivered impressive growth, posting a revenue CAGR of 23.5% and an operating income CAGR of 23.1%. This has resulted in TTM revenue of SEK 1.7 billion and operating income of SEK 340 million, yielding an operating margin of 19.9%. The company’s balance sheet includes cash of SEK 315 million compared nil debt and lease liabilities of SEK 81.9 million.

Market Data (as of Oct 6, 2025):

• Market Cap: SEK 14.0 Billion

• Share Price: SEK 303.5

• 52-Week Range: SEK 222 – SEK 447

• Analysts Price Target: SEK 368 (21.2% upside)

Valuation Multiples: IVSO currently trades at a discount to its historical averages:

• TTM EV/EBITDA: 34.0x (vs. a 5-year average of 59.6x)

• TTM EV/Sales: 8.1x (vs. a 5-year average of 10.8x)

2. Business Overview

a. The Story of Invisio AB

Founded in 1999 as a Danish entity named Nextlink.to A/S, the company has undergone several transformations. After restructuring under the Swedish parent company Nextlink AB in 2003-2004, it evolved through a series of name changes, becoming Invisio Communications AB in 2010 and finally INVISIO AB in 2020. The company was initially on the Nordic Growth Markets OTC list in 2004 and moved up to its current listing on the Nasdaq Stockholm Mid Cap on 2015.

The company’s growth was never straightforward as the first 13 years of INVISIO’s history required frequent raising of capital. A critical turning point occurred in 2008 when INVISIO abandoned the consumer market to focus exclusively on professional users. This pivot was led by Lage Jonason, a key figure who served as board member for over two decades (stepped down in October 2022). His conviction for this shift was based on a personal market observation:

“We put a lot of effort and money into producing the best product on the market…I then visited some electronics stores in London where the headsets were available to buy. They had received very good reviews in trade journals, but there was not a single store where the salesperson recommended our head set. Instead they pointed to alternatives from Motorola, Nokia and Samsung. My conclusion was that it’s not always the best product that wins the battle for the consumer, but factors such as brand... There and then I was entirely convinced that we must leave the consumer market and instead steer the entire company towards B2B. That has been our focus ever since.”

Jonason’s long-term commitment and financial support were instrumental in the company’s survival during its early, unprofitable years. He provided capital (and also helped in raising additional capital), strategy direction and market access. Other key decisions that shaped the company include the recruitment of CEO Lars Hansen in 2006, the establishment of a direct US sales organization in 2017 establishing the company as a credible supplier, the strategic launch of the Intercom system and the acquisition of Racal Acoustics.

Subscribe now

b. Business model

INVISIO develops and markets advanced communication systems that help professionals in noisy and mission-critical environments to work safely and effectively while protecting their hearing. The Company’s operations are highly focused on a global niche market of professional users and centered on two primary brands:

• INVISIO: Specializes in advanced in-ear headsets, control units, and personal communication systems for dismounted users (e.g. soldiers, police officers).

• Racal Acoustics: Acquired in 2021, this brand provides rugged over-the-ear headsets and communication systems for environments with constant high noise, such as inside armored vehicles (mounted) or around aircraft.

Product Offering

INVISIO’s product portfolio is comprised of four main categories: headsets, control units, intercom systems, and tactical hubs, along with a range of accessories.

INVISIO’s strength lies in its integrated ecosystem. The “plug-and-play” philosophy is the central nervous system of its offering, allowing users to seamlessly connect headsets, control units, and intercoms with intuitive ease. This approach encourages customers to adopt multiple Invisio products.

Personal Communications (INVISIO Brand): This is the heart of the dismounted soldier’s system. It provides a life-saving combination of crystal-clear communication and industry-leading hearing protection, all while preserving the full situational awareness needed to survive. A complete personal system consists of: a) a headset, offering advanced hearing protection and audio, b) a Control Unit which is the “brain” of the system, which centralizes power and connects the user to multiple communication devices (like radios) with the push of a button and c) the IntelliCable® which is a patented smart cable that ensures all equipment are interchangeable, even from other suppliers, giving it a core role in the modern soldier communication system.

Heavy Vehicle Communications (Racal Acoustics Brand): For crews operating inside an armored vehicle or near a jet engine, the challenge is constant, deafening noise. The rugged Racal headsets are engineered specifically for this environment, providing robust protection and clear communication links.

Intercom Systems (INVISIO Brand): This system is the bridge connecting the two worlds. It enables soldiers using their personal INVISIO gear to seamlessly connect to the vehicle’s internal communication network, talk to the crew, and access wider networks. It also facilitates seamless transition between different transport types such as land, sea and air.

Following its commercial breakthrough in 2023, the Intercom has become a major growth driver receiving high-volume orders in 2024. A fully equipped vehicle system valued at approximately €20,000 to €25,000 represents a cost that is far below that of traditional solutions. The system has evolved into a complete product family with recent additions including INVISIO Link™ and INVISIO Control™ App.

Research & Development (R&D)

The engine of INVISIO’s innovation is its commitment to Research & Development. Over a third of all employees are dedicated to building the next generation of technology, with the company investing 12–15% of revenue in R&D. INVISIO operates two centers of excellence: its headquarters in Copenhagen, focusing on personal systems and integration, and the UK facility, which builds on the legacy of Racal Acoustics to develop solutions for high-noise environments, as found in heavy vehicles.

Notable Innovations

AI-Powered Audio and Software: INVISIO has moved beyond being a hardware provider by integrating advanced software and Artificial Intelligence. The V-Series Gen II control unit platform is a prime example, using AI to achieve a 30% increase in speech clarity while also reducing power consumption by a factor of 80. This software-defined platform makes it simpler for customers to continually update and configure solutions based on specific mission requirements, providing user flexibility.

Expansion of the Intercom Ecosystem:

• INVISIO Link™: A module that enables wireless and encrypted communication for users in and around a vehicle, greatly increasing their mobility and operational effectiveness. This solution was developed in close collaboration with the US Defense Innovation Unit (DIU), a partnership that underscores INVISIO’s ability to create mission-critical solutions that meet the specific requirements of the most demanding end-users.

• INVISIO Control™ App: An intuitive software application that enhances the management and real-time visualization of the entire in-vehicle communication system.

“Yes. The Intercom and the Link, the interest is really, really high, and we have -- we’re just now ready to ship the first ready units to customers for testing and verification and hopefully soon getting into order phase. I do expect that to be a very significant contributor to the Intercom business over time. You can say that the Intercom product portfolio that we have has developed from when we started, it was a rather simple system with one box. Now it is a much more complete system, where you have an app for controlling the Intercom.” Lars Hansen in Q2’2025

Next-Generation Headsets

• INVISIO X7 (Launched 2024): This in-ear headset set a new benchmark. Independent tests confirm its groundbreaking hearing protection level of 39 dB SNR, which outperforms all other tactical alternatives. An X7 user can tolerate three times higher noise levels and manage eight times longer exposure than a user of the next-best alternative.

• INVISIO T30 (Announced Sept 2025): The T30 is one of the most important launches in the company’s history, strategically designed to win high-volume tenders from large standing armies (e.g. NATO forces). It offers market-leading protection (30 dB SNR) and unprecedented versatility, capable of operating standalone or fully integrated into the INVISIO ecosystem.

The H-Series Smart Hub: Announced in September 2025 and expected in 2026, the H-Series is a new generation of tactical smart hubs. Its purpose is to solve a critical battlefield problem: the complexity of managing multiple, often incompatible, devices. The H-Series will unify radios, sensors, End User Devices (EUDs), audio, and power into a single, intelligent system, aiming to drastically improve battlefield efficiency by reducing the operator’s cognitive load.

“This launch reflects the broader direction of INVISIO; delivering modular and scalable systems that are ready for what’s next in modern missions… It’s a step toward the kind of integrated systems that modern operations demand. We’re committed to leading that shift.” Lars Hansen, CEO.

Subscribe now

Go-to-Market Strategy & Sales Cycle

Sales operations are conducted primarily from the head office in Copenhagen and sales offices in the US, France, the UK, Italy and Thailand, and secondarily via a global partner network. Its go-to-market strategy is dictated by public-sector procurement processes, primarily in the defense and law enforcement sectors. This model is different from a standard B2B sales approach and has several defining characteristics:

• Long Sales Cycles: The process from initial contact to a secured contract is lengthy and resource-intensive, often spanning multiple years. It involves responding to formal tenders and dealing with extensive bureaucratic procedures.

• Rigorous Qualification: Products must pass extensive and demanding testing, both in independent labs and in field trials conducted by end-users, before being approved for procurement.

• Framework Agreements: The primary objective is to secure multi-year framework agreements or to be specified in large-scale modernization programs. These agreements, which typically run for three to seven years (or longer for vehicle contracts), establish INVISIO as a primary or exclusive supplier and facilitate repeat sales. They are also a powerful validation of INVISIO’s technological leadership.

This sales model creates significant barriers to entry. Once INVISIO’s systems are designed into a long-term program, the high technical and financial switching costs for the customer result in a strong moat.

Revenue Model

INVISIO’s revenue model is characterized by low visibility and high volatility (”lumpiness”) due to its reliance on large, infrequent government contracts. However, the company is strategically transitioning to a more predictable model by leveraging its integrated product ecosystem.

By providing a full suite of compatible products, INVISIO encourages customers to standardize on its platform. This increases the lifetime value of the customer and makes the relationship more resilient. This model also generates opportunities for follow-on sales. As per management estimates, revenue from replacements, software upgrades, and system expansions can equal at least 20% of the original order value annually.

Additionally, the expansion of the product portfolio and customer base over time has led to a notable increase in medium-sized orders. These orders help smooth revenue flows and reduce dependency on any single large contract award in a given quarter.

Read more

Following our February 2025 deep dive on AMD, we are now covering ASML, the company that produces the indispensable lithography machines used by every major chip manufacturer. In this write-up, we will provide a comprehensive overview of ASML, exploring its business model, technological monopoly, growth prospects, and valuation.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

Subscribe now

1. Key Facts

Description: ASML Holdings N.V. (ASML) is the global leader in lithography solutions, providing the critical Deep Ultraviolet (DUV) and Extreme Ultraviolet (EUV) machines that print circuit patterns onto silicon wafers. Its systems are indispensable to every major semiconductor fab, including TSMC, Intel, and Samsung and are essential for manufacturing the world's most advanced chips that power everything from smartphones to AI data centers.

Key Financials: From FY15 to TTM FY25, ASML achieved a revenue Compound Annual Growth Rate (CAGR) of 18.7% and operating income CAGR of 20.7%, reaching TTM FY25 revenue of €32.2 billion and operating income of €11.2 billion (34.8% operating margin). ASML holds €7.2 billion in cash and cash equivalents, compared to long term debt of €3.7 billion.

Price & Market Cap (as of 29 August 2025): Its market cap is €247 billion with a 52-week low of €508 and a 52-week high of €820, whereas it currently trades at €637.

Valuation: It trades at a LTM EV/EBITDA of 20x (5 Year average of 33.6x) and a LTM EV/Sales of 7.6x (5 Year average of 11.6x).

2. Business Overview

a. Lithography and its relation to Moore’s Law

To understand ASML’s critical role, it is good to first get a high-level understanding on the process of lithography: projecting light onto a silicon wafer to print the circuit patterns for transistors. In essence, lithography enables “shrink”: the reduction of transistor size. The machine determines the smallest features that can be printed on a chip and, therefore, the number of transistors that can be packed into a given area (more transistors means more powerful and energy-efficient chips).

This capability is fundamentally tied to two factors: the wavelength of light the machine projects on the wafer and the Numerical Aperture (NA) of the system's optics. A shorter wavelength allows for finer patterns, while a higher NA which you can think of as the optics' (mirrors and lenses) ability to gather light and focus it precisely also enables the printing of smaller features.

Together, these advancements in lithography are the engine behind Moore's Law, the famous observation by Intel's co-founder Gordon Moore that the number of transistors on a chip double approximately every two years. For decades, this doubling has been a direct result of continuous improvements in lithography technology. While the pace of shrink has slowed as physical limits are approached, it is still the primary path forward for the industry. The ongoing advancements made by ASML are what make this continued progress possible, reinforcing lithography’s position as the key driver for reducing both the cost and energy consumption per transistor.

b. The Lithography Machine

The primary objective of lithography is to reduce the cost per transistor by enabling chipmakers to produce the highest number of good transistors possible on a single chip. To achieve this, ASML builds machines of unprecedented scale and complexity.

A single EUV system is about the size of a city bus, contains over 100,000 parts, and costs upwards of $200 million. This immense cost and complexity are why a lithography system represents the single largest equipment investment a chip factory makes.

Source: ASML

Subscribe Now

c. The ASML Story

In 1984, ASM Lithography (later ASML) was born as a joint venture between Philips and Advanced Semiconductor Materials International (ASMI). The technology that formed the company originated in Philips's own research labs, where scientists had developed a "wafer stepper" to give their internal chip division a competitive edge. Seeing its potential, Philips decided to spin off the division to sell the machines externally but, seeking to limit its financial exposure, partnered with ASMI.

The company’s early years were a struggle. Its first commercial product, the PAS 2000, was not a financial success, but it introduced an innovative alignment technology that would become a cornerstone of ASML's future systems. While an improved machine, the PAS 2400, helped secure AMD as the first external customer in 1987, ASML still struggled to win over industry leaders like Intel and IBM, who were reluctant to switch from the era's dominant players, Nikon and Canon. Faced with continued funding needs, ASMI withdrew from the venture in 1988. However, a strategic investment by Philips into a new Taiwanese foundry, TSMC, opened the door for ASML to land the client that would eventually become its biggest customer.

The PAS 5500 and Modular Design

The true turning point came in 1991 with the prototype of the PAS 5500, a machine that helped ASML finally gain IBM as a client. Its breakthrough was a revolutionary modular design, a first in the industry. While its vertically integrated Japanese competitors built everything themselves in a monolithic system, ASML outsourced the manufacturing of individual modules to specialized suppliers. This design allowed for machines to be upgraded without being fully replaced and enabled a more capital-efficient business model. The longevity of this approach is remarkable; a stunning 95% of all systems ASML has ever shipped are still in operation. The company explicitly designs its systems with a 20-year lifetime in mind, which not only benefits customers but also creates a significant and stable revenue stream from its service and upgrade business.

IPO and the SVG Acquisition

With the success of the PAS 5500, ASML became profitable by 1993 and held its IPO in 1995, separating from Philips. The journey was not a straight line, as the company's fortunes were tied to the volatile semiconductor cycles. During the dot-com bubble, sales peaked at €2.8 billion in 2000, only to fall by 41% the following year; the stock took nearly 12 years to recover its peak price.

However, during this downturn, ASML made a pivotal strategic move, acquiring the US-based Silicon Valley Group (SVG) for $1.6 billion in stock. The acquisition was a masterstroke that accomplished two goals: it secured Intel, SVG’s largest client, and it brought in the foundational licenses for a new, undeveloped, and highly ambitious technology—EUV. This bet on the future would ultimately cement ASML's monopoly decades later.

The DUV Wall and Immersion

For many years, DUV lithography was the industry standard, using light with a 193-nanometer wavelength to print circuits. By the early 2000s, however, the industry's relentless push for "shrink" meant that chip structures were becoming finer than what DUV light could physically resolve.

While ASML initially made advances by improving the resolution of its lenses (increasing the Numerical Aperture), a more fundamental solution was needed. In the meantime, ASML introduced a stroke of genius: immersion lithography. By placing a thin layer of water between the machine's lens and the silicon wafer, ASML was able to effectively shorten the DUV wavelength and print even smaller features. Introduced in 2004, immersion technology was a critical bridge that kept Moore's Law alive while the industry worked on the ultimate, far more complex solution.

Source: ASML Investor Day Presentation 2024

A Collaborative Bet on EUV

The long-term answer was Extreme Ultraviolet (EUV) lithography, a revolutionary technology using an incredibly short wavelength of just 13.5 nanometers. However, the challenge was immense; it would take nearly two decades and billions of dollars to commercialize the technology for high-volume manufacturing.

ASML did not have the funds to finance the entire EUV research program and acquire its key supplier, Cymer (the US company developing the EUV light source). Doing so would have meant shouldering the risk for the entire industry. In an unprecedented move in 2012, ASML persuaded its largest customers, Intel, Samsung, and TSMC, to co-fund the project. They collectively invested approximately €5 billion in ASML in exchange for a combined 25% stake, ensuring the technology that was essential for their own future roadmaps would become a reality.

This journey has culminated in ASML's current market dominance: today, the company is the world's only manufacturer of EUV machines, holding a 100% market share, while also commanding a strong majority share of 80%- 90% in the DUV market.

Today, these two technologies serve different market segments. DUV systems are the workhorses used to produce mature chips for applications like cars and appliances, while EUV is essential for the most advanced chips powering smartphones and AI data centers.

d. The Outsourcing Model

Read more

In short, IDEXX provides veterinarians with a comprehensive suite of in-clinic diagnostic instruments, software, and external reference laboratory services that are critical for delivering modern animal healthcare.

The foundation of the company's immense success lies in its "razor-and-blade" business model. By placing its diagnostic instruments (the "razors") directly into veterinary clinics, often through multi-year commitment programs, IDEXX secures a predictable and highly profitable recurring revenue stream from the subsequent sale of consumables (the "blades") needed to run the tests. This strategy creates a powerful competitive moat and provides the business with revenue visibility.

In this report, we will dissect this business model, analyze the industry trends that support it, and conclude with a valuation of the company to determine if its shares represent an appealing investment opportunity at today's prices.

Without further ado, let’s dive in.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

Subscribe now

1. Key Facts

Description: IDEXX Laboratories (“IDXX”, “IDEXX”, and “Company”) is a global leader in the veterinary diagnostics market. It develops, manufacture, and distribute products and provide services primarily for the companion animal veterinary (the core business), livestock and poultry, dairy and water testing industries.

Key Financials: From fiscal year 2015 through the trailing twelve months (TTM) ending Q1 2025, IDEXX has delivered impressive growth, posting a revenue CAGR of 10.2% and an operating income CAGR of 15.9%. This has resulted in TTM revenue of $3.9 billion and operating income of $1.2 billion, yielding an operating margin of 30.7%. The company's balance sheet includes cash and short-term investments of $164 million compared total debt and lease liabilities of $1.1 billion.

Market Data (as of July 28, 2025):

• Market Cap: $45.6 Billion

• Share Price: $566.50

• 52-Week Range: $356.10 - $570.40 (currently trading near its 52-week high)

Valuation Multiples: IDEXX currently trades at a discount to its historical averages:

• TTM EV/EBITDA: 34.6x (vs. a 5-year average of 42.0x)

• TTM EV/Sales: 11.8x (vs. a 5-year average of 13.2x)

2. Business Overview

a. The Story of IDEXX

IDEXX Laboratories was founded in 1983 by David Evans Shaw (stepped down in 2002), who identified an untapped niche in animal health diagnostics. Starting with just five employees in Portland, Maine, the Company initially focused on creating reliable diagnostic tests for the livestock and poultry industries. A key strategic advantage in its early years was that veterinary products did not require the same lengthy and expensive FDA approval process as those for human use, allowing for rapid innovation. A major breakthrough was the development of the SNAP family of tests, which provided veterinarians with fast, accurate, in-clinic results.

Following a successful IPO on the NASDAQ in 1991, the Company used the infusion of capital to pivot its focus heavily towards the companion animal (pets) market. This strategic shift proved successful, establishing the Companion Animal Group as the core engine of growth and transforming IDEXX into the global leader it is today. Since its IPO, the Company has delivered an impressive annual total shareholder return of 20.6% (translating to 59,827% since inception) compared to 14.1% for Nasdaq 100.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers, premium members can benefit from a 3-month free trial)

a. Business model: The Razor-and-Blade Ecosystem

This model is primarily executed through Customer Commitment Arrangements, such as the IDEXX 360 program. In these multi-year agreements, customers receive free or discounted instruments in exchange for committing to purchase minimum annual amounts of products and services. These are often structured as reagent rental arrangements, where the clinic gets use of the instrument at little to no cost, locking them into the IDEXX ecosystem. To further strengthen these relationships, IDEXX provides incentives like upfront cash-equivalent points and volume-based rebates.

This strategy creates a competitive moat. High switching costs, driven by deep workflow integration and staff training, leading to exceptional customer retention rates, consistently reported in the high 90s. The moat is further deepened by an integrated software suite, including VetConnect PLUS and Vello, which centralizes patient diagnostic history and enhances client engagement, making it increasingly difficult for veterinarians to leave the ecosystem.

IDEXX delivers its Companion Animal Group (CAG) solutions through two modalities:

• Point-of-Care Solutions: In-clinic instruments that provide results within minutes while the patient is still in the practice.

• Reference Laboratory Services: A global network of labs where veterinarians can send samples for more complex tests, with results typically returned the next day.

Source: March 2025 presentation

The demand for the Company's core companion animal products is primarily driven by three factors: the number of patient visits to veterinary hospitals, the diagnostic protocols recommended by veterinarians, and the rate of pet owner compliance with those recommendations.

While the CAG is the core of the business (accounting for ~92% of sales), IDEXX also operates two other segments:

• Water (5% of sales): Provides testing solutions to detect microbiological parameters for government labs and water utilities.

• Livestock, Poultry, and Dairy (LPD) (3% of sales): Offers diagnostic tests to manage herd health and ensure milk safety and quality.

IDEXX employs a hybrid go-to-market strategy, primarily using a large, direct sales force to engage veterinarians in North America for its companion animal, reference lab, and imaging products. To expand its global footprint, the Company supplements its direct sales efforts with independent distributors and other resellers in certain international markets.

Regulation

IDEXX operates in a complex regulatory environment, which creates a significant barrier to entry for new competitors. In the US, its products are regulated by several federal agencies:

• USDA (U.S. Department of Agriculture): Oversees many of the veterinary diagnostic products.

• FDA (Food and Drug Administration): Regulates dairy products used in milk monitoring programs.

• EPA (Environmental Protection Agency): Approves test methods for water quality monitoring.

The company maintains licensed manufacturing facilities and must comply with a host of global product regulations, including those in the European Union. This stringent regulatory framework is a clear advantage that strengthens its market position.

Subscribe now

R&D

Innovation is the lifeblood of IDEXX’s strategy, enabling the Company to command premium pricing, deepen its moat, and expand its addressable markets. The Company's commitment is evident in its R&D spending, which has significantly accelerated in recent years.

In 2024, IDEXX spent $219.8 million (or 5.6% of revenue) compared to $191.0 million (or 5.2% of revenue) in 2023. The acceleration of this commitment is striking: IDEXX invested $1.2 billion in R&D over the last 7 years (2017-2024), matching the total amount it spent in the previous 20 years combined.

Source: March 2025 IDEXX presentation

While the company holds numerous patents, its strategy relies more on its innovative skills, brand strength, and integrated product offerings rather than any single piece of intellectual property, with the notable exception of key licenses related to its Catalyst platform.

A Timeline of Recent Innovation

IDEXX maintains a rapid pace of product launches and enhancements, consistently delivering new value to its customers.

• 2021: Successfully launched the ProCyte One Hematology Analyzer, its next-generation point-of-care platform, delivering over 2,500 units globally in its first year.

• 2022: Released eight new product, service, and software solution enhancements.

• 2023: Delivered six new enhancements and successfully prepared for the major launch of the IDEXX inVue Dx™ Cellular Analyzer.

• 2024: Achieved launch readiness for nine new solutions, began shipping the revolutionary IDEXX inVue Dx Cellular Analyzer in Q4’24, and launching the Vello software, a pet owner engagement tool that integrates with its key PIMS platforms and was adopted by nearly 600 practices by year-end (over 700 by Q1’25).

• 2025: Launched the IDEXX Cancer Dx panel in late March, expanded Catalyst menu with Cortisol test and remains on track to expand the inVue Dx menu with a fine needle aspirate capability for analyzing "lumps and bumps".

The Next Wave of Growth Platforms

Two recent innovations, the IDEXX inVue Dx and IDEXX Cancer Dx, are poised to become major long-term growth drivers.

1. IDEXX inVue Dx: Revolutionizing Point-of-Care Cytology

The IDEXX inVue Dx Cellular Analyzer, which began shipping in late 2024, marks a new era in point-of-care diagnostics.

• The Problem It Solves: Traditional cytology (the microscopic analysis of cells) is a laborious, technique-intensive process that requires significant hands-on time from a skilled veterinarian to read a slide.

• The Solution: The inVue Dx platform combines advanced optics with an AI model trained on millions of cellular images to deliver a revolutionary, slide-free, "load-and-go" workflow. It analyzes ear cytology and blood morphology samples in minutes, integrating the results seamlessly with the IDEXX VetLab Station and VetConnect PLUS.

• Market Opportunity & Traction: Customer interest has been exceptionally strong, with nearly 1,600 pre-orders by the end of 2024. IDEXX is targeting over 4,500 placements in 2025 and 20,000 over the next five years. The platform addresses a huge unmet need, as there are an estimated 19 million ear cytologies performed manually today, and an opportunity to add blood morphology analysis to another 20 million CBC tests annually. This is expected to contribute approximately $50 million in instrument revenue alone in 2025. Furthermore, the upcoming Fine Needle Aspirate menu expansion for inVue Dx will add another 11.5 million annual testing opportunities for evaluating common "lumps and bumps" in veterinary oncology.

• With over 900 placements of inVue Dx as of April 2025, including approximately 600 in April alone after gating controls were removed, IDEXX is on track for its full-year target of 4,500 placements. Over a longer horizon, management projects that the inVue installed base will approach a size similar to the ProCyte hematology platform.

Source: March 2025 IDEXX presentation

A quote from Tina Hunt, EVP of Global Strategy and Commercial, to sum it up:

“It is slide-free, load-and-go workflow with very minimal hands-on time. And this is a process. Before inVue, that was very laborious. It took a lot of time, but also it was very technique-intensive. So you really have a doctor coming in and reading the slide.

Now they just add the sample and they get the results. The results are available in the electronic medical record. They're quantifiable, but we provide interpretation information…we're off to a great start. And what we've indicated is 4,500 for the year and 20,000 over the next 5 years.”

2. IDEXX Cancer Dx: Tapping the Multi-Billion Dollar Oncology Market

Launched in March 2025, the IDEXX Cancer Dx is a pioneering diagnostic panel for the early detection of cancer, the leading cause of death in dogs.

• The Problem It Solves: Cancer in pets is often a "silent" disease that goes undiagnosed until it reaches late stages (Stage 3 or 4), when treatment options are limited and less effective. Demand for early cancer detection is exceptionally high, with 89% of veterinarians likely to add cancer screening to their wellness protocols and 73% of pet owners interested in such a test for their pet.

Source: August 2024 IDEXX investor presentation

• The Solution: IDEXX has launched an affordable reference lab panel, starting with lymphoma (which accounts for ~24% of canine cancers and has good therapeutic options if detected early), that can be added to routine wellness screens for as low as $15 (or $60 if it is a standalone test). The panel has a rapid 2-3 day turnaround time and will be expanded over the next three years to cover over 50% of the most prevalent canine cancers.

• Market Opportunity & Traction: IDEXX estimates the cancer screening opportunity for at-risk dogs in North America (estimated at 20 million) alone is $1.1 billion, within a broader oncology diagnostics market of ~$2.5 billion. The launch has seen strong initial interest, with over 1,000 unique practices ordering the test within the first month. This innovation not only creates a direct revenue stream but is also expected to help drive more pet owners into clinics for wellness visits (annual exam, routine check-up, vaccination).

Quotes from Tina Hunt, EVP of Global Strategy and Commercial, on the Cancer Dx Opportunity:

“Cancer is a leading cause of mortality in both dogs and cats, and it doesn't get diagnosed early enough…So that early detection is very important. So now to answer your question, Jon, on how we're thinking about it, there are about 13.5 million dogs that we believe have cancer and only about 1/4 of them get diagnosed. And as I mentioned, most of them get diagnosed much later. So that's where the aid in diagnosis is going to be very helpful.”

“There are about 20 million at-risk dogs in just North America alone. So when I say at risk, I'm talking about all dogs above the age of 7, they have a high risk for cancer and certain breeds above the age of 4. So if you put that together, that translates to about $1.1 billion opportunity for us with respect to the cancer screening.”

Production and supply chain

IDEXX employs a hybrid manufacturing model, producing many of its significant products in-house at facilities in the US and Europe, while also relying on third parties for certain instruments and critical components. A key aspect of its strategy involves securing long-term contracts with sole-source suppliers for essential consumables. For example, its agreement with Ortho-Clinical Diagnostics for Catalyst chemistry slides extends through 2044 and includes exclusivity clauses, protecting a critical part of its recurring revenue stream. This strategic management of suppliers, combined with the complexity of manufacturing its own biologic products, creates both a supply chain risk and a significant competitive advantage.

Regarding tariffs, the Company is relatively well-positioned due to its operational structure. With approximately 65% of revenues generated in the US and a largely US-based manufacturing footprint for its core CAG segment, IDEXX has limited exposure, particularly to China, which represents less than 1% of total revenue.

a. Segments

Companion Animal Group (“CAG”)

CAG is the core of IDEXX's business, representing approximately 92% of the Company’s revenue. This segment provides a comprehensive diagnostic and information management ecosystem for veterinarians, operating through two distinct but integrated modalities:

• Point-of-Care (POC) Diagnostics: This includes a suite of in-clinic analyzers for chemistry, hematology, and urinalysis, as well as single-use SNAP rapid assay tests. These handheld kits (the rapid assay tests) provide veterinarians with fast, accurate results for various diseases (such as canine heartworm or feline leukemia) in minutes, often without instrumentation.

• Reference Laboratory Services: A global network of approximately 80 laboratories where veterinarians can send samples for more complex testing and consultations. While expanding the reference lab network is key to growth, IDEXX notes that new and acquired labs may operate at a loss until they achieve sufficient scale, which can create a temporary drag on operating margins.

These modalities are seamlessly connected through a central hub, the IDEXX VetLab Station (IVLS), which consolidates all in-clinic diagnostic results. The IVLS then sends this data to the cloud-based VetConnect® PLUS software, providing veterinarians with a single, holistic view of a patient’s diagnostic history.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

CAG revenue is comprised of six distinct streams as shown in the above chart. The recurring components (defined as items regularly purchased by vets to perform ongoing diagnostic testing), the "blades" of the business model (stacked together in the above chart), are the most significant, with IDEXX VetLab Consumables and Reference Laboratory services being the largest contributors at 34% of sales each.

Recurring revenue now accounts for over 80% of total sales compared to 72% in 2015. This was primarily driven by the exceptional growth in high-margin consumables, which delivered a 14% CAGR over the period, reaching $1.3 billion in sales and a share of revenue of 34% Vs 25% in 2015. In contrast, instrument sales, the non-recurring "razors", were the slowest growth driver with just a 3% CAGR, reaching sales of $130 million.

In the most recent quarter, the CAG segment delivered organic growth of 4.4%, led by standout performance from IDEXX VetLab consumables (+10.5%) and the Veterinary Software and Services business (+7.5%).

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The importance of this mix shift cannot be overlooked. While instrument sales grow slowly, they enable the predictable, high-margin recurring revenue from consumables and services. This favorable shift, boosted by the high-margin Veterinary Software business, has driven a substantial increase in the company's operating profitability, from 17% in 2015 to nearly 31% by 2024 (when adjusted for a one-off litigation accrual – the case is closed now).

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The foundation of this recurring revenue stream is the Company's large and growing premium instrument installed base. The growing premium installed base indicates strong demand from veterinarians for in-house diagnostics that improve patient care and clinical decision-making. As of the first quarter of 2025, this installed base includes:

• Catalyst Analyzers: 75,100 units (+7% YoY), which are fundamental to in-clinic blood chemistry analysis.

• Premium Hematology Analyzers: Over 52,000 units (+8% YoY), including the ProCyte Dx and ProCyte One, providing crucial information on patient blood cells.

• SediVue Dx Analyzers: Over 22,000 units (+17% YoY), showing the most rapid expansion by automating urine sediment analysis.

Share

Source: Q1’25 IDEXX Earnings Snapshot

Source: March 2025 IDEXX presentation

This expansion of its installed base, combined with price realization and increased utilization, allowed IDEXX to outpace the annual growth of the broader veterinary sector by over 200 basis points over the past 5 years. The Company has achieved this despite recent headwinds in US clinic visit numbers, underscoring the value of its differentiated and integrated solutions.

Source: March 2025 IDEXX presentation

The success and stickiness of this model are supported by an exceptionally high customer retention rate, consistently reported in the 97-99% range. This retention rate, is supported by the Company's operational excellence, including its ability to maintain over 99% product availability and 98% on-time delivery for reference lab results.

Source: March 2025 IDEXX presentation

Looking ahead, the outlook for the CAG segment is strong, underpinned by a massive, underserved global addressable market estimated at over $45 billion. To capitalize on this, IDEXX is targeting 10%+ annual organic revenue growth, driven by the double-digit expansion of its recurring CAG Diagnostics revenue. This growth is expected to be fueled by three key drivers: new innovation platforms like inVue Dx and Cancer Dx tapping into multi-billion dollar opportunities; a core strategy to increase test utilization through veterinarian education about best medical practices; and the expected long-term growth in clinical visits driven by favorable pet ownership demographics and the aging of the large post-COVID pet population.

However, the Company must navigate a veterinary industry that is becoming increasingly consolidated. The growing scale of corporate hospital groups gives them greater buying power, which could impact profitability and supplier relationships over the long term.

Veterinary Software and Services & Diagnostic Imaging Systems

This is critical and high-growth component of the CAG ecosystem, providing the digital infrastructure that runs the modern veterinary clinic. Its core offerings are Practice Information Management Systems (PIMS), which manage key functions like electronic health records, scheduling, billing, and inventory. The portfolio includes the on-premise, highly customizable Cornerstone software and a suite of cloud-based platforms like the user-friendly ezyVet, Neo and the VetConnect PLUS. These systems are supplemented by a host of integrated tools for client communication (Vello), workflow management (VetRadar), and diagnostic image archiving (IDEXX Web PACS) creating a sticky software suite.

To support these solutions, post-contract support provides customers with access to technical assistance as needed through call centers and online portals. In addition, the segment includes diagnostic imaging systems, like the IDEXX ImageVue DR series, which capture digital radiographs to replace the traditional chemical-based x-ray film process.

Source: IDEXX August 2024 Investor Presentation

This segment accounts for approximately 8% of total Company sales and, with a 12.1% CAGR from 2015-TTM, is the second-fastest growing part of the business behind VetLab consumables. It generates relatively high margins from its subscription-based products, with recurring revenue comprising 80% of the segment's sales (the rest comprises of hardware and digital imaging system).

As CEO, Jay Mazelsky noted: “IDEXX software helps clinics unlock the full potential of their diagnostics, improve client engagement and enhance operational efficiency. This quarter, we saw strong performance across our practice information management system as well as pet owner engagement tools like Vello. Our ezyVet and Neo platforms continue to grow as we deliver double-digit placement growth in our leading cloud-native PIMS during the quarter with accelerated momentum.”

Growth is driven by a dual strategy of organic innovation and strategic acquisitions, as the majority of the Company's M&A activity is in software. Major acquisitions like ezyVet (2021) and Greenline (2024) have been significant contributors to growth. For example, these acquisitions boosted sales by 10.5% in 2021 (out of 26.6% total growth), 7.9% in 2022 (out of 21.8% total growth), and 4.7% in 2024 (out of 11.9% total growth).

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The business has excellent momentum driven by the rapid shift to the cloud, with 61% of the PIMS installed base now being cloud-native (compared to 29% in 2020) and 98% of new placements in 2024 being cloud-based systems. Meanwhile, recent performance has been strong, with double-digit placement growth in leading cloud PIMS and Vello users (introduced in 2024) growing over 20% in Q1 2025 from the prior quarter.

Source: March 2025 IDEXX presentation

The software portfolio is a key strategic focus and the Company is targeting 15%+ annual recurring revenue growth from this segment. The overarching strategy is to continue driving cloud adoption and leveraging the fully integrated software ecosystem to deepen the competitive moat, making it indispensable to a clinic's daily workflow.

Water quality products (“Water”)

This segment provides innovative testing solutions for the detection and quantification of various microbiological parameters in water. Its principal products, like the Colilert tests, are used by government laboratories, water utilities, and private certified labs to ensure the safety of drinking water, bottled water, and water used in production processes.

The Water segment, which accounts for approximately 5% of total sales, is the Company's most profitable with an operating margin of around 46%, significantly higher than the CAG segment's margin (+30%). It has grown at a 7.4% CAGR since 2015 and continued its strong performance into the most recent quarter, delivering 7% organic revenue growth in Q1 2025 driven by a combination of price increases and higher testing volumes.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

The future growth in the segment is dependent on the Company's ability to increase international sales and broaden its product line. As the market is largely driven by regulation, it provides a stable, albeit smaller, source of revenue and profit for the company.

Livestock, Poultry and Dairy (“LPD”)

The LPD segment provides diagnostic tests, services, and related instrumentation used to manage the health of herd animals and to ensure the quality and safety of milk from contaminants like antibiotic residues. Its customers are primarily government and private laboratories that provide testing services to producers and livestock veterinarians.

LPD is the smallest segment, accounting for only 3% of total sales and posting a negative CAGR of -0.4% since 2015. It operates at a near break-even level of profitability, with a 5.7% operating margin, a significant decline from the double-digit levels observed in the past. Demand can be volatile, influenced by specific disease outbreaks or government-funded programs, though the segment did grow 4% organically in Q1 2025.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

Given its small scale and low profitability, this segment is not considered a primary long-term growth driver for IDEXX, especially when compared to the significant opportunities within the Companion Animal Group and its software portfolio. This raises questions about its long-term strategic fit within the company.

Geographies

IDEXX's business is centered in the US, which generates 65% of total revenue, while international markets account for the remaining 35%. Outside of the US, the largest markets are Germany (4.5%), Canada (3.9%), and the U.K. (3.5%). The importance of international sales varies significantly by segment, accounting for only 33% of CAG revenue but a substantial 82% of LPD and 48% of Water revenues.

While the US market is more profitable due to higher spending by US pet owners, the international segment grew faster in 2024 (7.5% vs 5.9% for the US) and in Q1 2025, as international CAG recurring revenue grew at a robust 8.5% organically, well ahead of the 3% growth in the US market (affected by the 2.6% drop in clinical visits), driven by strong new business gains and a rapid expansion of its premium instrument installed base.

3. Management

a. Culture

IDEXX's company culture appears to be solid and improving, with no significant warning signs. The Company's Glassdoor rating is 3.5, with 64% of employees recommending it to a friend and 58% approving of the CEO. While these metrics are below competitor Zoetis, they are higher than Antech Diagnostics.

Source: Glassdoor

More importantly, internal metrics point to a strengthening culture. The Company's overall voluntary employee turnover rate has shown a clear downward trend, declining from 13.3% in 2022 to 8.5% in 2024. This improvement may be partially attributed to initiatives like balancing reference lab shifts to reduce employee overtime and burnout.

Perhaps the strongest indicator is that IDEXX achieved an employee Net Promoter Score that was above the 90th percentile for all employers, according to data from its third-party engagement platform.

b. Leadership

IDEXX is led by a stable and experienced management team, with a strong culture of promoting leaders from within the organization.

CEO: Jonathan J. Mazelsky was appointed President and CEO in October 2019, having been with IDEXX since 2012, previously serving as Executive Vice President for the North American CAG business. The transition was unexpected, following a tragic cycling accident that resulted in a paralyzing spinal cord injury to the former long-serving CEO, Jonathan Ayers. However, the Board's well-planned emergency succession protocols enabled a smooth and seamless leadership transition without disrupting the business.

CFO: The Company has also managed a smooth CFO transition in 2025. The retiring CFO, Brian McKeon, was succeeded by Andrew Emerson, effective March 1, 2025. This was another promotion from within, as Mr. Emerson had been with IDEXX since 2015, leading finance for the critical CAG business and overseeing corporate finance functions since 2020.

The broader executive team reflects a culture of commitment and long tenures, with many members having joined IDEXX over a decade ago, including one executive who has been with IDEXX since 1999.

Under the leadership of CEO Jonathan Mazelsky, the Company has executed well, missing earnings consensus just once while delivering a total shareholder return of approximately 110%, translating to a CAGR of around 13.4%.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers, premium members can benefit from a 3-month free trial)

c. Compensation

IDEXX’s executive compensation is heavily weighted towards performance, creating alignment with shareholder interests. It consists of a base salary, an annual cash bonus, and long-term equity awards.

The annual bonus is tied to a blend of financial metrics (60% weight), including organic revenue growth, operating profit, EPS, and ROIC, and non-financial goals (40% weight). The Board sets challenging targets that are not "lowballed", as evidenced by the 81% achievement rate against the financial goals in 2024. These targets are dynamic. For instance, following the strong performance in 2023, 2024 targets were raised for key metrics like organic growth (to 8.5% from a 7.8% target in 2023) and ROIC (to 49.1% from 44.5%).

Source: 2024 Proxy Statement

Long-term incentives consist of a mix of stock options and time-based RSUs, both of which vest in equal installments over a four-year period, and Performance-Based Stock Units (PSUs). The PSU vesting is tied to achieving multi-year organic growth and operating profit targets over a three-year performance period, ensuring executives are rewarded for long-term value creation.

In line with other US companies, IDEXX’s compensation program is heavily weighted towards "at-risk" pay to ensure alignment between leadership and shareholder interests. In 2024, 91% of the CEO’s and 84% of other senior executives' target compensation was variable and dependent on performance.

d. Ownership

While directors in aggregate own just 0.98%, leadership’s financial interests are aligned with shareholders through substantial direct holdings relative to their salaries.

The CEO, Jonathan Mazelsky, directly owns shares worth over $45 million, and his total potential ownership, including exercisable options, is valued at approximately $190 million. This represents a value far exceeding the Company's requirement to hold 10 times his base salary of $1.15 million. Additionally, the former long-serving CEO, Jonathan Ayers, maintains a substantial position, holding shares worth over $320 million (approximately 0.7% of the Company).

Leave a comment

4. Industry

The companion animal health market is underpinned by powerful and enduring secular trends. These forces are reshaping consumer spending and creating a resilient, high-growth environment for industry leaders like IDEXX.

a. Key Macro & Demographic Trends

• The “Humanization” of Pets: Owners increasingly view their pets as integral family members. This emotional bond translates into a higher willingness to spend on premium products. This trend is clearly visible in purchasing habits; after a brief decline in 2023, premium pet food purchases regained momentum in 2024. According to the APPA, 41% of dog owners and 38% of cat owners purchased premium food in 2024, representing a 5% and 9% increase from the previous year, respectively.

• The Pet Population Boom & Generational Shift: The total US pet population is expanding rapidly, with 94 million households now owning at least one pet, a significant increase from 82 million in 2023. This includes 68 million households with a dog and a fast-growing 49 million with a cat. This growth is largely driven by younger generations, with Gen Z and Millennials now the dominant pet-owning cohorts. These younger owners are also more likely to own multiple pets; a remarkable 70% of Gen Z pet owners have two or more pets. The deep integration of pets into daily life is further evidenced by behavioral trends, such as the increasing number of owners traveling with their dogs and a strong desire for dog-friendly workplaces.

Source: The American Pet Products Association (APPA) Releases 2025 State of the Industry Report

• The Economics of Companionship: This trend is occurring alongside a consistent decline in US fertility rates, which fell from 2.12 children per woman in 2007 to a low of 1.62 in 2023 (replacement factor is estimated at 2.1). A key factor in this shift is cost as raising a child to age 18 in the US averages over $300,000, while annual pet care is significantly lower at around $1,500-$1,800. For younger generations, pets offer companionship without the same long-term financial commitment, a trend that is reshaping consumer spending patterns.

• Pets Are Living Longer: Advances in veterinary care are having a profound impact. The average lifespan of cats has increased by 18% (to 14.4 years) and dogs by 16% (to 13.4 years) since 2010. This is a powerful growth driver, as older pets utilize significantly more healthcare and diagnostics.

Source: IDEXX March 2025 presentation

b. Market Size & Forecasts

The global addressable market for companion animal diagnostics is massive, estimated by IDEXX at over $45 billion. The most compelling aspect of this market is that it remains significantly underserved, with only ~15% of the total opportunity currently being addressed.

Source: IDEXX August 2024 Investor Day

While the industry has faced a headwind of declining clinical visit numbers over the past three years (down ~2.6% in the latest quarter), this is being offset by an increase in the quality and value per visit, driven by higher diagnostic utilization and a continued willingness from pet owners to invest in innovative care.

That being said, the key long-term growth factors for the industry remain clear:

• Increasing Diagnostic Utilization: A primary growth lever is educating veterinarians to increase the frequency of diagnostic testing. Currently, only about 12% of US clinical wellness visits include bloodwork, though “top practices” that standardize diagnostics use them more than twice as often as the average practice, uncovering underlying issues in 25-35% of cases.

Source: IDEXX March 2025 investor presentation

• International Expansion: Market penetration is even lower outside of North America (22% served), with Europe at just 8% and Latin America at 2%. This presents a vast runway for growth, with the international market expected to grow at a faster rate (10%+) than the U.S. (8%).

Source: IDEXX March 2025 presentation

• Continued Innovation: New testing capabilities and menu expansions, such as those in oncology, create new reasons for testing and drive higher spending per visit, ensuring that the quality and value of each visit continue to improve.

c. Competition Landscape

While many smaller regional players exist or subsidiaries of large conglomerates like Thermo Fisher, the primary competition for the core CAG segment comes from two global companies:

1. Zoetis Inc. (NYSE: ZTS): Zoetis is a dominant force in animal health, but primarily in pharmaceuticals and vaccines. Diagnostics represents a small and less strategic portion of its business, accounting for just 4.2% of its total revenue in 2024.

• Scale Comparison: Zoetis's diagnostics revenue was approximately $386 million in 2024, which is minimal compared to IDEXX's CAG revenue of $3.6 billion. This highlights IDEXX's clear leadership and focused expertise in the diagnostics market.

• Growth: While Zoetis's diagnostics growth was strong in Q1 2025 at 25.6%, its full-year growth in 2024 and 2023 was 2.7% and 6.5%, respectively, showing a more volatile trajectory compared to IDEXX's consistent expansion of 10% in 2023 and 7% in 2024.

2. Mars, Incorporated (Private): Mars is a strong competitor through its aggressive acquisition strategy, primarily via its Antech Diagnostics and Heska brands. As Mars is a private company, direct financial comparisons are unavailable, but analysis of its components reveals IDEXX's superior scale.

• Antech Diagnostics: Antech is a strong competitor, particularly in the reference laboratory space, with a US network of approximately 70 labs, which is larger than IDEXX's. Since Antech's global financials are private, an estimate was derived from its UK subsidiary's reported 2023 sales of £24.7 million (comprised of £3.3M from the UK, £9.9M from the rest of the EU, and £11.6M from the rest of the world). Applying the 3.5% weight of IDEXX's own UK business as a conservative proxy suggests Antech's total global revenue is approximately $932 million (£706 converted to USD), still smaller than IDEXX's CAG segment.

• Heska: Prior to its acquisition by Mars, Heska's financials demonstrated the gap between IDEXX and smaller competitors. In 2022, Heska generated $257 million in revenue with just 1.4% growth, compared to IDEXX's CAG revenue of $3 billion with 6% growth in the same year.

While IDEXX faces competition in specific areas, such as from Covetrus in the software market, its primary challengers in the core diagnostics space are Zoetis and the expanding Mars portfolio. However, IDEXX’s scale, higher growth rate, and deeply integrated “razor-and-blade” ecosystem solidify its position as the dominant leader.

5. Financial Analysis

a. Performance

From FY15 to Q1’25 TTM, IDEXX delivered a 10.2% revenue CAGR, reaching $3.9 billion. Gross profit grew at an 11.4% CAGR, with margins improving from 55.6% to 61.3% while operating income rose from $308 million to $1.2 billion, reflecting a 15.9% CAGR and a 30.7% operating margin. Over the past decade, free cash flow margin averaged 15.8%, with FY24 FCF at $808 million or 20.7% of revenue.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers), StockOpine analysis

IDEXX has a track record of delivering strong and profitable growth. While the Company strategically acquires reference labs and software companies, its growth has been primarily organic, driven by the powerful recurring revenue engine of the CAG segment.

Organic growth has been a dynamic interplay of several key drivers, with their respective importance shifting over different periods:

• Pre-COVID (2017-2019): Growth was balanced, with net price increases of 2-3% complemented by a 3-4% growth in clinical visits, alongside benefits from increased test utilization and the expansion of the instrument installed base.

• COVID-Era (2020-2021): This period saw an exponential increase in clinical visits (growing 6-7%) as pet ownership surged. This volume growth, combined with continued price increases of 3-4%, had a profound impact on revenue.

• Post-COVID (2022-2024): As clinical visit numbers normalized and declined, price realization became the most important driver of growth, contributing 6-7% annually. That being said there is an optimism for a return to growth at 3% for clinical visits (we touch this on the outlook).

In the most recent quarter (Q1 2025), revenue growth was comprised of a 4% contribution from price and a 2% contribution from volume.

Source: IDEXX August 2024 Investor presentation

Gross margins have consistently expanded, rising from 55.6% in FY15 to 61% in FY24, and reaching 62.4% in Q1'25. This improvement is a direct result of the favorable mix shift towards high-margin recurring CAG Diagnostics revenue (especially VetLab consumables) and effective price realization.

The strength at the gross profit level has translated directly into higher operating margins, which grew steadily from 19% in 2015 to 30.5% in 2024. The most recent quarter's operating margin stood at 31.7% (or 30.8% when adjusted for a one-off litigation accrual reversal), demonstrating a clear and sustainable trend of profitable growth.

Free cash flow margins have generally moved in line with the growing operating profitability, expanding from 8.7% of sales in 2015 to 20.7% in 2024. The only recent exception was in 2022, which saw a temporary negative impact from inventory management that was quickly resolved the following year.

Backlog: A Leading Indicator of Future Growth

A key metric for understanding IDEXX's future growth is its backlog of committed future revenue from multi-year customer arrangements. As of Q1 2025, the Company estimated this backlog to be approximately $4.7 billion.

This backlog has been growing faster than current sales, which is a strong positive indicator of the accelerating momentum. This is because a multi-year contract is added to the backlog in its entirety upfront, while revenue is only recognized annually. The rapid growth of this figure compared to current sales is driven by several factors:

• Successful placement of new instruments into clinics coming with a new multiyear agreement.

• High rates of customer contract renewals and extensions, often at higher values and possibly at longer terms.

• A shift towards more advanced instruments that carry higher minimum purchase commitments.

As CFO Andrew Emerson confirmed, recent large corporate contracts were both “expansions and extensions”, increasing the duration of relationships and the breadth of services used.

The fact that this backlog is growing faster than recognized sales indicates that future revenue is becoming more predictable and secure, the instrument installed base is expanding successfully, and customer loyalty is exceptionally high.

Source: IDEXX financials, StockOpine analysis

b. Financial position

IDEXX maintains a flexible financial position. As of Q1 2025, the Company's balance sheet included $164 million in cash and short-term investments against approximately $1.1 billion in total debt and lease liabilities. While IDEXX operates with a net debt position, its leverage is very manageable.

The debt is well within its covenant requirements as its debt to adjusted EBITDA ratio stood at a safe 0.58x in Q1 2025, far below the 3.5x maximum. Furthermore, IDEXX has significant liquidity, with over $928 million in remaining borrowing availability under its credit facility. The Company’s strong free cash flow, which reached $808 million in 2024, provides ample capacity to easily cover all debt maturities falling due over the next three years, and management retains the flexibility to reduce its share buyback program if needed to prioritize deleveraging.

Source: Q1’25 10Q

c. Capital allocation

IDEXX has a clear and shareholder-friendly capital allocation strategy. Between fiscal years 2015 and 2024, it generated approximately $5.6 billion in operating cash flow. Of that, it allocated $1.1 billion (20%) to net capital expenditures, $363 million (6.5%) to acquisitions, and the vast majority of $4.4 billion (79%) to share repurchases. This approach emphasizes reinvestment in the business while delivering consistent shareholder returns, primarily via buybacks, which have reduced the total share count by 10.3% since 2015.

The Company has been particularly active and opportunistic with its buyback program. For example, it accelerated repurchases in Q1 2025, spending $400.9 million at an average price of ~$439.7 per share. In hindsight, this proved to be a timely decision, as the share price increased by 25% in the months that followed. After a slowdown in 2023 to prioritize debt repayment, IDEXX guided for approximately $1.5 billion in share repurchases for 2025 with 5.2 million shares available as of 31 March 2025.

Acquisitions represent a smaller but important part of IDEXX's capital allocation strategy. These are bolt-on acquisitions designed to enhance existing business lines, particularly in software. The vast majority of M&A spending has been focused on bolstering the technology portfolio, with key examples including the acquisitions of ezyVet (2021) and Greenline (2024). IDEXX has a good track record of integrating these purchases, with no goodwill impairments recorded in recent years.

The effectiveness of this capital efficient strategy is demonstrated by IDEXX’s impressive returns. Return on Invested Capital (ROIC) has expanded significantly, rising from 17.3% in 2015 to 39.7% in 2024.

Source: Fiscal.ai (affiliate link with a 15% discount for StockOpine readers)

d. Outlook

IDEXX, in Q1’25, has revised its outlook for 2025, adjusting reported revenue and operating margin due to favorable foreign exchange rates and a litigation accrual adjustment. The guidance is based on the assumption that the recent trend of a ~2% decline in US clinical visits will persist for the full year.

Key updated targets for 2025 include:

• Revenue: $4.095 billion - $4.210 billion, representing 6% - 9% organic growth (5-8% reported).

• CAG Diagnostics Recurring Revenue: 5% - 8% organic growth (4-7% reported), supported by an anticipated full-year price realization of 4% to 4.5%.

• Operating Margin: 31.1% - 31.6%, maintaining its outlook for 30 - 80 basis points of comparable operating profit margin expansion, even after absorbing headwinds from tariffs and lower-margin inVue Dx placements.

• Earnings Per Share (EPS): $11.93 - $12.43, representing 8% - 12% growth on a comparable basis.

• Capital Expenditures: Estimated to be approximately $160 million.

Long-Term Multi-Year Goals

IDEXX's long-term growth is driven by a massive and underserved instrument placement opportunity, representing a runway of over 320,000 potential new units. Consequently, it has established multi-year financial goals that reflect its confidence in its durable business model:

• Organic Revenue Growth: 10%+ annually

• Annual Operating Margin Gains: 50 - 100 basis points, driven by software, price realization and growing mix of CAG recurring revenue

• Annual EPS Growth: 15% - 20%

This growth is expected to be driven by software and services 15% annual growth, a double-digit expansion in CAG recurring revenue (11-14%), which management believes will be achieved through a combination of net price increases, new business from installed base expansion, and a reversal of the recent trend in clinical visits. As EVP Tina Hunt explained, IDEXX has confidence in a return to 3%+ annual clinical visit growth over the long term, driven by powerful tailwinds, including pets living longer, rising adoption by younger generations, and the large "bolus" of pets adopted during the COVID pandemic now aging into a life stage that requires more intensive diagnostic care.

Furthermore, CFO Andrew Emerson has highlighted the role of innovation in this algorithm, noting that new innovations are expected to contribute approximately 2% to the long-term annual growth rate.

Source: IDEXX August 2024 investor day

6. Competitive Advantages, Opportunities and Risks

Competitive Advantages

• Integrated “Razor-and-Blade” Ecosystem: IDEXX's primary advantage is its business model. By placing a massive installed base of diagnostic instruments ("razors"), the Company locks in a highly predictable, multi-year stream of high-margin recurring revenue from the sale of proprietary consumables ("blades"). This model is difficult to replicate at scale and is the foundation of its financial strength.

• High Switching Costs & Sticky Customer Base: The deep integration of IDEXX's instruments (via the IVLS) and software (PIMS, VetConnect PLUS) into a clinic's daily workflow creates extremely high switching costs. This ecosystem effect, combined with the Company's operational excellence (e.g., 99%+ product availability), results in exceptionally high customer retention rates, consistently in the 97-99% range.

• Scale and Regulatory Barriers: As the clear market leader with a revenue scale in diagnostics, IDEXX benefits from significant operational leverage. Furthermore, the Company operates in a complex and stringent global regulatory environment (overseen by the USDA, FDA, and EPA in the US), which creates a barrier to entry for new and smaller competitors.

• Continuous Innovation Engine: The Company’s moat is built on a continuous R&D engine that consistently delivers a broad, integrated portfolio of best-in-class products. This relentless pace of innovation, rather than patent protection alone, is a key competitive advantage that is difficult for competitors to replicate.

Refer a friend

Opportunities

• New Innovation Platforms: The Company’s growth will be fueled by its next wave of innovation. The IDEXX inVue Dx Cellular Analyzer and the IDEXX Cancer Dx panel are tapping into new, multi-billion dollar addressable markets in cytology and oncology, respectively, where there is immense unmet demand from both veterinarians and pet owners.

• Increasing Diagnostic Utilization: The global companion animal diagnostics market, estimated at over $45 billion, remains massively underserved (only ~15% penetrated). A core opportunity for IDEXX is to increase the frequency of testing per clinical visit by educating veterinarians on the medical and financial benefits of a higher standard of care.

• International Expansion: The international market represents a substantial long-term growth opportunity. With diagnostic penetration in key regions like Europe at just 8% (compared to 22% in North America), there is a long runway to place instruments and drive recurring revenue growth.

• Expansion of the Software Ecosystem: With a target of 15%+ annual recurring revenue growth, IDEXX is capitalizing on the industry's shift to cloud-based software. By growing this high-margin business through both organic innovation and strategic acquisitions, it deepens its competitive moat and increases its share of clinic spending.

Risks

• Veterinary Industry Consolidation: An increasing percentage of veterinary hospitals are being acquired by large corporate groups and buying consortiums. These entities have significant buying power and often seek favorable pricing from suppliers. Furthermore, some of these corporate owners operate their own competing reference laboratories, creating a risk that they could shift testing away from IDEXX after acquiring a clinic.

• Economic Slowdown: Demand for companion animal care is sensitive to the broader economy, as pet owners generally pay for services out-of-pocket. A significant economic slowdown could lead to a reduction in pet-owner spending on diagnostics. It could also cause veterinarians to defer purchasing or upgrading capital items like IDEXX's in-clinic analyzers.

• Key Supplier Reliance: IDEXX depends on sole-source suppliers for critical components, most notably the Catalyst consumables, which are secured through an exclusive agreement with Ortho-Clinical Diagnostics extending to 2044. While this long-term contract provides supply security, any disruption would significantly impact production as finding and qualifying a replacement would be a difficult and lengthy process.

7. Valuation

The stock price as of 28th of July 2025 stands at $566.5 with a year to date return of 37%. The Company's market capitalization is $45.6 billion and it trades at an EV/EBITDA TTM multiple of 34.6x. Based on our DCF valuation, the estimated price of IDEXX is $447, ~21% lower than its current price, and an expected IRR over the projected period of 4.5%.

Source: StockOpine analysis

Revenue Assumptions

To estimate IDEXX’s fair value, we assume a revenue CAGR of 7.4% through fiscal year 2029, reaching approximately $5.6 billion. While our revenue growth assumption is below management's long-term organic growth target of 10%+, we believe it is a prudent forecast, as the Company's actual growth in 2024 (6.5%) was below that target. Our model is underpinned by the following key segment growth assumptions:

• IDEXX VetLab Consumables: 11.6% CAGR (vs. a historical CAGR of 14%)

• Reference Laboratory Diagnostics: 4.5% CAGR (vs. a historical CAGR of 10.9%)

• Veterinary Software: 11.4% CAGR (vs. a historical CAGR of 12.1%)

Profitability Assumptions

We forecast the EBITDA margin to average 35.4%, expanding to a terminal margin of 36.4%. This is above both the 5-year historical average of 31.7% and the 33.9% margin achieved in fiscal year 2024.

Our forecast is built by starting with the 2024 margin of 33.9% which is expanded by an average annual margin of 50 basis points. This assumption is aligned with the lower end of management's long-term guidance for 50-100 basis points of annual operating margin expansion and is consistent with their 2025 guidance for 30-80 basis points.

Free Cash Flow and Capital Expenditures

We assume capital expenditures will be 3.9% of revenue, aligned with IDEXX’s FY25 guidance of $160 million and is also consistent with the Company's 5-year historical average. After accounting for taxes and working capital, we estimate a terminal FCF margin of 22.8%. This is above the 5-year historical average of 17.3% (adjusted for stock-based compensation) and reflects our expectation of sustained high profitability.

Terminal Value

For the terminal value, we applied a 25.0x EV/EBITDA multiple. This is well below IDEXX’s current TTM multiple of 34.6x and its 5-year historical average of 42.0x.

In a peer context, our chosen multiple is in line with the 5-year average for Zoetis (25.8x) but represents a premium to its current multiple of 18.0x. We believe this premium is justified by IDEXX’s superior capital efficiency, as demonstrated by its ROIC of over 35% compared to approximately 24% for Zoetis.

While we view 25.0x as an appropriate multiple, the accompanying sensitivity analysis illustrates a range of outcomes. Based on this analysis, even with a higher terminal multiple, IDEXX appears to be richly valued at its current price.

Valuation summary

To calculate intrinsic value, we apply a 10% discount rate, adjust for net debt and non-operating assets/liabilities, and then divide by the total number of shares outstanding.

Based on our model, the fair value per share is $447, which is 21% lower than the current market price, implying an IRR of 4.2% over the forecast period.

a. The Valuation model

Here’s the full year-by-year financial projections from our model.

Source: StockOpine analysis, Note: The reported FCF for 2024 was $808M. The $747.8M figure used in our analysis is a normalized FCF that has been adjusted to deduct SBC. For the purpose of this analysis, we treat SBC as a cash expense. The 2025 FCF figure reflects a manual deduction of the FCF generated in Q1.

b. Sensitivity analysis

The tables below illustrate the sensitivity of our valuation to key assumptions, showing the potential upside or downside relative to the current share price of $566.5 (as of July 28, 2025).

The first analysis varies the terminal EV/EBITDA multiple and the discount rate, while the second varies the terminal EV/EBITDA multiple and the terminal EBITDA margin. As shown, the valuation appears rich across a range of scenarios, suggesting limited upside potential from the current price.

Source: StockOpine analysis

8. Conclusion

IDEXX Laboratories is the undisputed global leader in veterinary diagnostics, built upon a masterfully executed “razor-and-blade” model that has created a durable competitive moat. This strategic excellence is reflected in its stellar financial performance, characterized by consistent organic growth, steadily expanding margins, and an impressive Return on Invested Capital.

Looking ahead, the Company has clear runways for future growth from its innovation pipeline, increasing test utilization, and international expansion. However, this operational excellence appears to be fully reflected in the stock's current rich valuation. While IDEXX is a high-quality business we would be proud to own, the current share price does not offer a sufficient margin of safety. A significant pullback to the levels seen near its 52-week low of approximately $360 would present a compelling entry point.

Disclaimer: The team does not guarantee the accuracy or completeness of the information provided in the newsletter. All statements express personal opinions based on own financial and business analysis. Any estimates or forward looking statements made are inherently unreliable. No statement of opinion is an offer or solicitation to buy or sell the financial instruments mentioned.

The content of our newsletter is not a trading or investment advice and we do not provide any personal investment advice tailored to the needs of any recipient. The information provided should not be considered as a specific advice on the merits of any investment decision. Securities trading involve risk and you might lose your capital and/or incur other damages. Investors should make their own research and consult their registered investment advisor or financial advisor before taking any investment decision.

Neither the team nor any of its affiliates accept any liability whatsoever for any direct or indirect loss however arising, from any use of the information contained herein. Any unauthorized copy of this newsletter or its contents is illegal.

Our posts may contain affiliate links, which means that we might get a commission if you decide to sign-up using any of these links. No extra cost is charged to you.

By subscribing / reading our newsletter or any affiliated social media accounts, you indicate your unconditional acceptance to the above and your unconditional acceptance to our terms and conditions.

From its humble origins in a Swiss watchmaking valley, Straumann has not only led this space for decades but has consistently outpaced its peers in growth, profitability, and returns on capital.

This analysis will dissect Straumann’s multi-brand strategy, which enables it to compete effectively across all price points—from premium to value. We will also explore its strategic push into digital dentistry, a move designed to create a sticky, integrated ecosystem for dental professionals. Finally, we will benchmark Straumann against its key competitors and assess whether this high-quality company offers an attractive entry point at its current valuation.

Without further ado, let’s dive in.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

Subscribe now

1. Key Facts

Description: Straumann Holding AG (Ticker: STMN) is a global leader in dental implants and orthodontic solutions. The company develops, manufactures, and markets dental implants, CADCAM prosthetics, clear orthodontic aligners and digital solutions used in tooth restoration, replacement, and preservation.

Key Financials: From FY15 to FY24, Straumann achieved a revenue and operating income Compound Annual Growth Rate (CAGR) of 14%, reaching FY24 revenue of CHF 2.5 billion and operating income of CHF 625 million (25% operating margin). Straumann has debt and lease liabilities of CHF 414 million compared to cash and cash equivalents of CHF 376 million.

Price & Market Cap (as of 25 June 2025): Its market cap is CHF 16.6 billion with a 52-week low of CHF 83 and a 52-week high of CHF 141, whereas it currently trades at CHF 104.

Valuation: It trades at a LTM EV/EBITDA of 21.4x (5 Year average of 33.4x) and a LTM EV/Sales of 6.7x (5 Year average of 10.4x).

Join +7,800 subscribers

2. Business Overview

a. The Straumann Story

The history of Straumann dates back to the early 1950s, founded by Reinhard Straumann in Switzerland, it began as a research institute and family business, specializing in advanced alloys for the country's famed watchmaking industry. Its expertise in material science led to a pivotal shift in the 1960s, when the company began developing non-corroding alloys for treating bone fractures, marking its entry into medical technology.

The true turning point came in 1974 with the production of its first titanium hollow cylinder dental implants, laying the foundation for what would become the Straumann Dental Implant System. This move was solidified in 1980 with the co-founding of the International Team for Implantology (ITI), a global academic organization that has since become a cornerstone of Straumann's scientific credibility and educational outreach.

Under the leadership of the founder's grandson, Thomas Straumann, the company sharpened its focus exclusively on dental implantology in 1990. This was followed by a series of breakthrough innovations such as:

• SLA Surface (1997): A revolutionary surface treatment that halved implant healing times.

• SLActive Surface (2005): An even more advanced surface that further improved treatment outcomes and solidified the brand's premium reputation.

The company's 1998 IPO on the Swiss stock exchange provided the capital to fuel its ambitious global expansion and cement its market leadership.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers, premium members can benefit from a 3-month free trial)

b. Business Model: Multi-Brand Strategy and Integrated Ecosystem

Straumann's business model is centered on a multi-brand strategy designed to capture market share across all price segments and geographies. Since implant dentistry is a high-cost elective procedure rarely covered by insurance, offering a range of price points is critical for market penetration.

The flagship Straumann brand anchors the premium end of the market, commanding high prices backed by decades of clinical research and a reputation for quality.

Recognizing the threat from lower-priced competitors and the immense growth potential in emerging markets, the company built a powerful portfolio of "challenger"/value brands through strategic acquisitions. This expansion into the value segment is bearing fruit, as it consistently grows faster than the premium segment.

“On the global perspective, when we look at our two different brands, premium and challenger, then challenger is growing always faster than premium, but premium is also very, very strong. And we can say that we are almost double digit on both sides with having -- with our challenger brands being able to, of course, be much more dynamic because of the geographical mix, once again, having all those emerging markets growing faster from a volume standpoint and all being at 90%-ish in the challenger side.” Guillaume Daniellot, CEO

Key acquisitions in the value portfolio included:

• Neodent (Acquired 2012-2015): A dominant Brazilian value brand that now leads Straumann's charge in LATAM and has expanded its global footprint to over 90 countries.

• Medentika & Anthogyr: These value brands, acquired in stages, strengthened Straumann's challenger portfolio in Europe and globally. Straumann acquired a controlling stake in Medentika in 2017 and took full ownership of French implant maker Anthogyr in 2019

Source: Annual Report 2025

Simultaneously, Straumann has expanded into high-growth adjacencies. The 2017 acquisition of ClearCorrect gave it a strong foothold in the booming clear aligner market, putting it in direct competition with the incumbent, Align Technology ( ).

This entire brand portfolio is being unified by an integrated digital ecosystem. By offering intraoral scanners, milling machines, 3D printers, and the Straumann AXS software platform, the company aims to deepen its relationship with dental professionals and create significant switching costs.

This marks a dramatic transformation. In 2013, nearly 95% of revenue came from Straumann-branded premium implants. By 2024, the revenue mix had significantly diversified with digital equipment, value implants, and the Orthodontic gaining share, estimated to account for around 40% of the Company’s total revenue.

Source: Straumann Investor Presentation Q1’25

Read more

This company made its way onto our watchlist after standing out in one of the various screeners we regularly run. While it may be under the radar for most investors, it's certainly not for us, since we’re based in Cyprus, where the company has a strong presence. That’s why we think it’s worth bringing to your attention.

Whether or not the stock is currently attractively priced is something we’ll explore in the valuation section, but one thing is clear: it’s a solid defensive name that deserves a spot on your radar.

Without further ado, let’s dive in.

Subscribe now

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

1. Key Facts

Description: Jumbo S.A. (Ticker: BELA - “Jumbo”, “Company”) is a leading diversified retailer known for its affordable pricing and broad product offering, primarily focused on toys, baby products, stationery, seasonal items, and home goods. The Company offers over 40,000 SKUs and operates 89 owned/leased stores across Greece, Cyprus, Bulgaria and Romania, and has presence in North Macedonia, Albania, Kosovo, Serbia, Bosnia, Montenegro and Israel through 40 franchised stores operating under the JUMBO brand.

Key Financials: Over the period FY15 to FY24, the Company depicted a revenue Compound Annual Growth Rate (“CAGR”) of 7.4% and operating income CAGR of 11.7%, reaching an FY24 revenue of €1.1 billion and adjusted operating income of €372 million (margin of 32.4%). Jumbo has cash and short term investments of €444.8 million compared to nil total debt and lease liabilities of €75 million.

Price & Market Cap (as of 30th May 2025): Its market cap is €3.85 billion with a 52-week low of €21.68 and a 52-week high of €29.04, whereas it currently trades at €28.62.

Valuation: Jumbo trades at a TTM EV/EBITDA of 8.2x (5 Year average of 7.2x) and a TTM EV/Sales of 3.0x (5 Year average of 2.5x).

2. Business Overview

a. The Story of Jumbo S.A.

Jumbo S.A. was founded in 1986 by Apostolos Vakakis, who opened the first toy store in Glyfada. But Jumbo’s roots stretch back further, to Vakakis’s upbringing in a business-minded Greek family.

Born in Alexandria, Egypt in 1954, Vakakis came from a family that fled political unrest during the Nasser revolution, resettling in Greece in 1962. His father, George, had produced insulation materials and later worked in a toy-making workshop in Italy. This exposure led the family to establish the toy company El Greco in Greece, which Apostolos helped rebuild after a devastating fire in one of its manufacturing facilities in mid 80s. In 1985, he took over leadership of the company and eventually sold it to Hasbro in 1990, remaining involved as an executive within Hasbro Europe.

By then, Vakakis had already shifted toward retail, having founded Jumbo in 1986. With its big-box format and low-price model, the brand quickly resonated with Greek consumers. A major milestone was achieved in 1997, when Jumbo went public on the Athens Stock Exchange, enabling access to capital markets.

In 1998, it acquired Jumbo Trading Ltd in Cyprus, followed by entry into Bulgaria in 2007 and Romania in 2013. Vakakis essentially expanded into neighboring markets with cultural similarities and logistical advantages. It’s worth noting that apart from the fire during the El Greco years, bad luck struck again in 2000 when a fire destroyed Jumbo’s headquarters and warehouse. The Company then moved its base to Moschato, where it is still located today.

One of its most noticeable achievements came in 2004, when Jumbo secured exclusive rights to produce and distribute the Athens Olympic mascot, helping push annual revenues towards €500 million.

Today, the company operates 89 owned or leased stores in Greece, Cyprus, Bulgaria, and Romania, along with 40 franchised stores in Southeast Europe and Israel. Its retail model, a hypermarket without food, fashion, or electronics, features over 40,000 SKUs and continues to draw strong consumer traffic.

Source: Company’s 2024 Annual Report

Jumbo remains a family-influenced business, as Vakakis still owns 16.4% and serves as a Chairman while Vakakis’s daughter Sophia now serves on the Board as an executive member. His younger daughter Christina pursued her passion for culinary arts, while his son George tragically passed away in a car accident in 2017, a loss that deeply affected the family.

From a single toy shop to a regional retail force, Jumbo has delivered an impressive 14.6% annual total shareholder return since IPO, built on conservative growth, operational discipline, and a product mix designed to endure across cycles.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers, premium members can benefit from a 3-month free trial)

b. Business model

Jumbo S.A. operates a value-driven retail model. From the outset, Jumbo has maintained a low-price strategy to foster trust and long-term customer loyalty. Founder Apostolos Vakakis recently reaffirmed this focus, stating:

“There's absolutely no desire to adjust prices upwards. We would be more than happy to adjust prices downwards and pass theoretical gains to our customers in order to consolidate our future…So we always have to be very careful not to create a gap.”

While primarily a retailer, Jumbo also engages in limited wholesale operations requiring strong credit histories from partners to mitigate default risk.

In recent years, Jumbo has strategically moved from leasing to owning stores to reduce operating costs. Between FY2020–FY2024, the Company acquired five previously leased stores for €39M, and most new store rollouts in 2023–2025 are company-owned. Vakakis explains:

“Leasing a store would cost us, let's say, 7.5%, 7% on the estimated value of the store, while owning the store, especially if you are liquid, is 0%.

While Vakakis prefers owning stores to avoid lease costs of 7–7.5%, this strategy draws some criticism. With returns on capital near 20%, critics argue that the capital tied up in real estate could be better used to fund growth or returned to shareholders, a classic opportunity cost trade-off. Still, this reflects Vakakis’s conservative mindset, focused on long-term cost control.

To his credit, this hasn’t limited growth or shareholder returns as Jumbo continues to pay dividends and recently started a buyback program.

Subscribe now

Sourcing, Supply Chain & Risk Management

Roughly 70% of Jumbo’s products are sourced from Asia, particularly China. The Company acts as the exclusive importer for several international toy manufacturers not represented in Greece, while also purchasing from 200+ local suppliers. None of its suppliers represents more than 3% of turnover limiting concentration risk and strengthening its bargaining power.

Source: Jumbo Annual Reports, StockOpine analysis

However, the Company is not immune to global supply chain disruptions. Jumbo manages this by investing heavily in logistics infrastructure and building up inventory buffers when needed. To improve supply chain resilience, the Company owns advanced warehousing and distribution centers in Greece, Cyprus, and Romania (footprint of c. 560.000 sqm), supporting both physical and online operations. Jumbo also plans to add two new distribution hubs, one in Thessaloniki for Northern Greece/Bulgaria and another in Oinofyta for the rest of Greece and exports, with over €60M in investment over the next 3–5 years.

In the near term, the Company stands to benefit from favorable sourcing dynamics, including lower costs from Chinese suppliers and potential pricing leverage due to the US-China tariff tensions and a stronger euro. However, these tailwinds are inherently volatile and short-lived. While margins may benefit temporarily, the long-term outlook remains uncertain, reinforcing the need for supply chain agility.

Seasonality & Inventory

Jumbo’s sales are highly seasonal, with approximately 28% of annual revenue generated in December (Christmas), 12% in April (Easter), and 10% in September (back-to-school). This seasonality requires effective inventory management to minimize the risk of obsolete stock.

In practice, inventory write-offs remain low, highlighting Jumbo’s effective forecasting and stock control across peak periods.

Source: Jumbo Annual Reports, StockOpine analysis

Branding & Advertising

Brand recognition is a key competitive strength for Jumbo, closely associated with products for every occasion at affordable prices. The “JUMBO” brand is trademark-protected through 2032 and promoted through high-visibility TV and social media campaigns, often characterized by a clever, unconventional tone.

One standout example was the 2023 Easter campaign in Greece, where a popular singer was humorously depicted singing about the traditional Easter barbecue, on the moon, after being banished from Earth by vegans. Contradictory, yes; but undeniably effective in capturing public attention and reinforcing Jumbo’s brand visibility.

c. Geographic Segments

The Group reports four core geographical segments, namely, Greece, Cyprus, Bulgaria, and Romania. Greece remains the largest market, with 53 stores and revenue of €559.8 million (excluding franchise collaborations), accounting for 52% of the total sales mix, down from 73.3% in FY2015.

Romania has been the fastest-growing market. Since 2015, the number of stores has increased from 6 to 20, and revenue has grown from €24.3 million to €252.2 million in FY2024, reflecting a CAGR of 27.9%.

In terms of profitability, Greece leads with a gross profit margin of 56.9% in FY2024, averaging 56% over the past five years. Cyprus has the lowest, yet still healthy, margin at 52.1%, with a five-year average of 52.4%.

Read more

This deep dive explores how Intuit, with its iconic brands like QuickBooks, TurboTax, Credit Karma, and Mailchimp, has evolved into a fintech powerhouse. We'll analyze its growth, dissect its business model, and assess whether its stock price offers an attractive investment today.

Subscribe now

Without further ado, let’s dive in.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Industry

5. Financial Analysis

6. Competitive Advantages, Opportunities and Risks

7. Valuation

8. Conclusion

1. Key Facts

Description: Intuit is a financial and marketing software company operating under four brands; QuickBooks, TurboTax, Credit Karma and Mailchimp. The Company serves mostly small and mid-size entities (SMEs), self-employed individuals and consumers. Its services include among others, accounting software, payroll processing, merchant payment processing, tax preparation, provision of financing, marketing automation tools, and financial marketplace for consumers.

Key Financials: From FY15 to trailing twelve months (TTM) Q2’25, Intuit achieved a revenue Compound Annual Growth Rate (CAGR) of 16%, reaching TTM revenue of $17.2 billion while its operating income increased at a CAGR of 17.4% to $4.1 billion (23.6% operating margin). Intuit has debt and lease liabilities of $6.9 billion compared to cash and short-term investments of $2.5 billion.

Price & Market Cap (as of 24 April 2025): Its market cap is $172 billion with a 52-week low of $532 and a 52-week high of $715, whereas it currently trades at $615.

Valuation: It trades at a LTM EV/EBITDA of 36x (5 Year average of 40.0x) and a LTM EV/Sales of 10.3x (5 Year average of 11.7x).

Through its brands Intuit serves approximately 100 million people. Intuit was incorporated in 1984 and became public in 1993. Since its IPO it compounded returns at 19% CAGR, becoming a 260x bagger since. As noted below, most of the exponential growth of Intuit’s returns were beyond 2015, which is the time the Company started the migration to the cloud and solely offering subscription-based services.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

In fact, the Company’s revenue from FY2005 to FY2015 grew at a CAGR of 7.7% while from FY15 to TTM it grew at a CAGR of 16%. Notably, over the last 20 years Intuit had only one down year and that was in 2015 where revenues declined by 1% and operating margin declined from 31% to 21% as revenues were impacted by the transition of its Desktop services from one-time license sales to subscription-based.

1. Business Overview

Intuit's core strategy revolves around creating a powerful ecosystem of interconnected financial tools for consumers and small businesses. This involves:

• Platform Approach: Integrating its key products (QuickBooks, TurboTax, Credit Karma, Mailchimp) to provide a seamless user experience and cross-selling opportunities.

• AI-Driven Innovation: Leveraging AI to automate tasks, provide personalized insights, and enhance the value proposition of its products.

• Expanding the Ecosystem: Adding new services (e.g., payments, payroll, lending) to increase customer lifetime value. This strategy aims to not only acquire new customers but also to deepen relationships with existing ones, ultimately driving sustainable long-term growth.

Lets now delve into Intuit’s key products.

a. QuickBooks: The Engine of Intuit's Growth

QuickBooks is the core product of Intuit. Initially launched as an accounting software, it has since evolved into a comprehensive platform providing a suite of financial and management services tailored for SMEs. In fact, QuickBooks is the most popular accounting solution for SMEs in the U.S. and is recognised as a leader in the space by G2 Grid Scoring.

Source: G2.com

Intuit's strategy involves onboarding customers through its online accounting software and subsequently upselling additional services such as payroll, payments, and financing. The beauty of the attached services such as merchant payments and payroll processing, is that as Intuit’s customers become bigger, Intuit earns more fees from those services, with limited incremental cost (other than direct intercharge and processing fees).

Overall, the QuickBooks ecosystem subscriptions and its attached services (payments, payroll, etc) is estimated to be around 50% of Intuit’s total revenue growing in the range of 20% per annum.

QuickBooks Accounting

QuickBooks Accounting is the accounting software. Intuit sells QuickBooks Accounting subscriptions at multiple-tier plans according to customer needs. Within QuickBooks Online (QBO), Intuit’s cloud-based solution, Simple Start, Essential and Plus tiers are more suitable to self-employed and small businesses while the Advanced tier and the Intuit Enterprise Suite are more suitable to mid-sized entities.

Source: Intuit

Post-2015 cloud migration, QuickBooks Online experienced significant growth. By 2019, QBO had approximately 4.5 million paid subscribers, up from around 1 million in 2015. As of FY24, Intuit reported that its Online Ecosystem customers grew by 6% to reach 8.3 million. Assuming Mailchimp accounts for about 1 million subscribers and standalone services (payroll/time tracking) remain stable at 0.3 million, we estimate that QBO subscribers reached approximately 7 million in FY24, marking a 7% year-over-year growth and a CAGR of 9% since 2019.

QuickBooks Payments

QuickBooks Payments offers merchant services that are tightly integrated into the QuickBooks ecosystem. This integration streamlines reconciliations and collections for users. Intuit earns processing fees, typically around 3% for card payments. As customers scale, QuickBooks Payments scales with them. In FY24, QuickBooks Online Payments processed $124 billion in total payment volume compared to $104 billion in FY23, growing at 20% year-over-year in FY24 and 25% in FY23. In Q2’25, payment volume growth stood at 18% year-over-year. Merchant services along capital and checking accounts are part of Intuit’s “Money” Portfolio which reached revenue of $1B in FY24, growing revenue 36% year-over-year.

Subscribe now

QuickBooks Payroll

QuickBooks Online Payroll helps companies process employee payroll and automate tax payments. It's available both as an integrated solution with QBO and as a standalone product. According to Intuit’s 2024 Investor Day, 18 million U.S. workers are paid through QuickBooks Payroll annually—significantly higher than Paychex (payroll solution for SMEs in US), which processes payroll for around 12 million employees.

In FY24, Intuit’s Payroll reached $1.1 billion in revenue, growing 23% year-over-year while total online payment volume growth in payroll was 18% in Q2. Intuit estimates a $23 billion global addressable market for its workforce solutions which includes payroll and time tracking for employees.

QuickBooks Capital

QuickBooks Capital provides small business loans by leveraging the financial data already available within customers’ QuickBooks accounts. Businesses can apply for term loans directly through Intuit or gain access to funding via third-party lending partners. In addition, the QuickBooks Line of Credit offers pre-approved, flexible borrowing up to a set limit, giving businesses added financial agility.

In FY24, QuickBooks Capital facilitated $2.4 billion in loans, marking a 28% year-over-year increase. Intuit holds a sizable portion of these loans on its balance sheet—originated both directly and through loan purchases from partners. As of fiscal year-end, net notes receivable for term loans stood at $912 million, up 20% YoY. This balance rose to $1.2 billion by Q2 FY25, up 31.6%, and now accounts for approximately 15% of Intuit’s tangible assets.

It’s important to note that these are unsecured loans which are exposing Intuit to potential credit losses, in the event of a downturn. This risk is heightened by current trade policies, where tariffs fuel recession concerns. Small businesses which are Intuit’s core lending base, are typically more vulnerable than large-sized enterprises during economic stress, making this segment particularly exposed.

Intuit Enterprise suite and QuickBooks Advanced

Launched in September 2024, Intuit Enterprise suite (IES) targets businesses with over $3 million in revenue or up to several hundred employees—an upmarket push toward the mid-market. IES is part of QuickBooks Online Ecosystem and it is offered on a subscription basis. Initial contracts have an ARPC (Average Revenue Per Customer) of ~$20K, significantly higher than the other QBO tiers. As IES is more suitable for complex workflows and is catered to mid-size entities which have lower failure rates than small entities, IES subscribers also have higher retention, boasting an 88% renewal rate compared to 82% for the overall QuickBooks Online ecosystem and 84% for Quickbooks Advanced.

Though early, this offering shows strong momentum. In fact January 2025 contract signings were 2x those of November 2024 and win rates for businesses with $10M+ revenue are 2x higher than smaller businesses. And Intuit, plans to push for more growth by hiring 200 salespeople to push the products.

Intuit estimates the larger and mid-market businesses represent a $89 billion TAM and wants to penetrate this market through its QBO Advanced and Intuit Enterprise Suite. In fact, in Q2’25, QBO Advanced and IES had 40%+ revenue growth, suggesting strong momentum in the company's efforts to serve mid-market customers.

“And that's about $100 billion in TAM, and that's where QBO Advanced, Intuit Enterprise Suite and all the services truly as a platform come in. We believe mid-market 1 day will be bigger than the entire business group. That's why we started talking about the growth rate of mid-market separately because it's an area where we're getting great traction. It's an area where we have actually more confidence today than even 5 years ago when we declared disrupting mid-market, given our expansion of our innovation on the platform but also our go-to-market. And we're not going to stop at a couple of hundred million in revenue. We believe we have so much more room. And we just have so much more confidence sitting here today than even last fall because we're in market with Intuit Enterprise Suite, and we can see how we're winning on experienced total cost of ownership and price” Sasan Goodarzi

The growth opportunity doesn’t just lie in acquiring new customers but it also comes from Intuit’s existing installed base. The company estimates that 800,000 current QuickBooks customers qualify for an upgrade to either QuickBooks Advanced or IES. Given that QuickBooks Advanced generates five times the ARPC compared to the standard QBO offering and IES delivers even higher ARPC—this presents a meaningful opportunity to drive revenue growth through customer upgrades.

Read more

To make things easier, paid subscribers will receive a downloadable PDF at the end of this article, combining both parts into a single, easy-to-read report.

Let’s jump in.

Subscribe now

3. Management

a. Culture

According to Glassdoor ratings, Fortinet ranks lower than its peers in overall score, CEO approval, and the percentage of employees willing to recommend the company to a friend. Nonetheless, its 3.9 rating is not concerning, and with 4 out of 5 employees approving the CEO, we don’t see any significant cultural issues.

Source: Glassdoor

b. Leadership

Fortinet’s leadership team, anchored by its co-founders Ken Xie (CEO and Chairman) and Michael Xie (President and CTO), has been a key driver of the company’s success. Their vision and expertise have shaped Fortinet into a cybersecurity leader, and the stability of their leadership remains critical to achieving the company’s strategic objectives. In a notable transition, longtime CFO Keith Jensen, who has been with Fortinet for 11 years, announced his retirement effective May 15, 2025. He will continue supporting the company until June 30, 2025, and will be succeeded by Christiane Ohlgart. Ohlgart, currently Fortinet’s Chief Accounting Officer, brings over 30 years of experience, including previous roles as CFO at IGEL Technology and VP of Finance at Fortinet. Her deep familiarity with the company ensures continuity in financial leadership. Additionally, in July 2024, Fortinet’s Board of Directors established a dedicated Cybersecurity Committee, an uncommon but strategic move that underscores the company’s commitment to proactively managing cybersecurity risks in an increasingly fast-paced and complex environment.

c. Compensation

Fortinet’s 2024 proxy statement highlights a strong emphasis on performance-based compensation, with 96% of the CEO’s total compensation and 93% for other named executive officers (NEOs) tied to performance. Stock-based compensation accounts for 91% of the CEO’s pay and 86% for NEOs. While restricted stock units (RSUs) are primarily service-based, performance-based pay still constitutes 60% for the CEO and 59% for NEOs—higher than CrowdStrike’s ~50% but below Palo Alto Networks’ ~97.6% for the CEO and 94.2% for NEOs, which rely solely on performance stock units (PSUs).

The compensation structure includes a base salary, annual bonuses tied to revenue (70%) and operating income (30%), and equity awards. Performance-based PSUs vest over four years (20% each of the first three years, 40% in the fourth) based on Fortinet’s total shareholder return (TSR) relative to S&P 500 companies. RSUs vest over four years, with 25% vesting after one year and the remainder monthly thereafter.

In 2023, Fortinet reintroduced PSUs to NEO equity compensation, granting an equal split between time-based RSUs and performance-based PSUs. CEO Ken Xie’s total compensation of $16.3M remains significantly lower than CrowdStrike’s $47M and Palo Alto’s $58M, indicating a more conservative pay structure. The Company’s consistent outperformance of earnings expectations suggests that its compensation strategy aligns leadership incentives with long-term shareholder value.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers, premium members can benefit from a 3-month free trial)

d. Ownership

Fortinet scores well on insider ownership, with its CEO, CTO, and the Xie Foundation collectively holding 16.9%. While this is lower than the 19.5% reported in the 2024 proxy, it remains a significant stake, reinforcing strong alignment between management and shareholder interests.

Subscribe now

4. Industry

Fortinet operates in a highly competitive cybersecurity landscape, facing rivals such as Palo Alto Networks, CrowdStrike, Zscaler, Cisco, Microsoft, SentinelOne, Check Point and more. While some competitors focus on cloud-based security, others integrate security features into their broader networking and infrastructure solutions.

The cybersecurity market is rapidly evolving, driven by advancements in AI, cloud computing, and secure networking. AI-powered threat detection and automated security responses are becoming essential as cyber threats grow more sophisticated. The rise of generative AI has also enabled large-scale social engineering attacks, with Gartner predicting that by 2027, 17% of cyberattacks and data leaks will involve AI. Meanwhile, cloud security adoption is increasing as organizations migrate workloads, with the combined cloud access security brokers (CASB) and cloud workload protection platforms (CWPP) market expected to grow from $6.7 billion in 2024 to $8.7 billion in 2025.

Read more

As part of this year's goal to consolidate our portfolio and explore complex yet critical industries, we’re diving into new sectors to broaden both our own knowledge and that of our readers while ensuring our portfolio remains strategically positioned for the future.

Our paid subscribers received an update in the chat on Friday, March 14, where we detailed the portfolio adjustments made following the recent market drawdown.

Cybersecurity is a fast-growing industry with secular tailwinds that should keep Fortinet on a strong growth trajectory. We believe AI strengthens security needs, making this an even bigger opportunity. The recent acquisition by Alphabet of cybersecurity firm Wiz, raising its offer from $23 billion last year to $32 billion, further highlight the sector’s momentum. With so much happening, sitting on the sidelines may not be the best long-term strategy.

This report on Fortinet’s business model turned out longer than expected, but we found the additional depth necessary for better understanding. Therefore, the sections on Management, Industry, Financial Analysis, Competitive Advantages, Valuation, and Conclusion will be covered in Part 2, releasing next week. Paid subscribers will also receive the full report in a pdf.

Without further ado, let’s dive in.

Subscribe now

1. Key Facts

Description: Fortinet Inc. (“FTNT”, “Company”) is a cybersecurity leader, pioneering the convergence of networking and security. Its integrated platform, Fortinet Security Fabric, spans secure networking, AI-driven security operations (SecOps), and unified SASE to protect people, devices, and data. Founded in 2000 and headquartered in California, Fortinet delivers high-performance cybersecurity solutions to enterprises, service providers, government agencies, and SMBs, offering automated protection, detection, and response across the digital attack surface.

Key Financials: Over the period FY15 to FY24, the Company depicted a revenue Compound Annual Growth Rate (“CAGR”) of 21.8% and operating income CAGR of 61.4%, reaching an FY24 revenue of $5.96 billion and operating income of $1.8 billion (margin of 30.2%). Fortinet has cash and short term investments of $4.07 billion compared to total debt and lease liabilities of $1.07 billion.

Price & Market Cap (as of 17th March 2025): Its market cap is $74.3 billion with a 52-week low of $54.6 and a 52-week high of $114.8, whereas it currently trades at $96.7.

Valuation: Fortinet trades at a NTM EV/EBITDA of 30.7x (5 Year average of 32x) and a NTM EV/Sales of 10.5x (5 Year average of 9.5x).

2. Business Overview

a. History

Fortinet was founded in 2000 by brothers Ken Xie (CEO) and Michael Xie (CTO), launching its flagship FortiGate firewall as its first product in 2002. The next-generation firewall (NGFW) was a major technological leap, introducing deep inspection and advanced detection features, surpassing traditional network firewalls that merely acted as gateways between local area networks (LAN) and the internet. Over time, FortiGate evolved to integrate capabilities such as IPS (Intrusion Prevention System), VPN support, and application control, enhancing security beyond basic packet filtering.

Over the next two decades, Fortinet expanded beyond firewalls, transforming into a comprehensive cybersecurity platform that includes SD-WAN, cloud security, endpoint security, wireless access points, sandboxing, email and web security, and more. This expansion led to what the company now calls the “Fortinet Security Fabric”—an integrated suite of security and networking solutions. Today, the Fabric spans over 50+ enterprise cybersecurity products and serves more than 830,000 customers worldwide.

Fortinet Security Fabric Portfolio

Source: Investor Day March 2025

Ken Xie, who still serves as CEO, was born in China and previously founded NetScreen in 1996, an ASIC-based firewall pioneer that Juniper Networks acquired for $4 billion in 2004. His deep industry experience played a crucial role in shaping Fortinet’s early strategy.

By 2004, Fortinet had rapidly expanded its presence across Asia, Europe, and North America and by 2008 the company turned profitable. In 2009, it went public. Since its IPO and taking into account its five-for-one stock split in June 22, 2022, Fortinet has delivered a 5,708% total return to shareholders, translating to a 30%+ CAGR over more than 15 years, making it one of the largest pure-play cybersecurity companies.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

While Fortinet’s growth has been primarily organic, it has also pursued strategic acquisitions to enhance its offerings. Recent acquisitions include Lacework and Next DLP, which we will cover later.

Despite its leadership in cybersecurity, Fortinet itself has faced security breaches. Notable incidents include:

• A critical authentication bypass vulnerability in FortiOS VPN (2021), which resulted in 500,000 login names and passwords being leaked on hacking forums.

• A 2022 breach (CVE-2022-40684), where a hacker group obtained data from 15,000 Fortinet firewalls, allegedly linked to a state-sponsored actor.

• Most recently, the company announced patches for new zero-day vulnerabilities (CVE-2024-55591), affecting FortiOS and FortiProxy.

These incidents underscore a critical challenge in the cybersecurity industry, i.e. even leading security providers remain targets of malicious attacks. Ultimately, in this industry, trust is everything, and losing customer confidence is a key risk Fortinet and its peers must constantly mitigate.

Subscribe now

b. Business model

Fortinet operates through a two-tiered distribution model, selling its security solutions to distributors, including Arrow Electronics, Inc., Exclusive, Ingram Micro, and TD Synnex, who then supply network security-focused resellers, service providers, and Managed Security Service Providers (MSSPs). These resellers and service providers, in turn, sell to end-customers or use Fortinet’s products and services to offer hosted security solutions to other enterprises.

This distribution model has played a crucial role in Fortinet’s broad market reach, particularly in the SMB (Small and Medium-Sized Business) segment, which, despite not driving large enterprise deals, remains the backbone of economies, making it a key market for Fortinet’s security solutions. The Company’s strong firewall unit shipments and market leadership (see image below) stem in part from its ability to efficiently serve this segment.

Distributors are critical to Fortinet’s strategy, as in 2023 and 2024, sales from the top three distributors made up 57% and 56% of total revenue, highlighting Fortinet’s dependence on this network. However, distributors do not necessarily hold significant bargaining power in this relationship. Historically, vendors have switched distributors when necessary, with new distributors often eager to invest in the vendor’s growth to capture market share.

Read more

The explosive demand for AI has driven us to explore this space further. Given the industry’s complexity, our goal this year is to deepen our understanding to ensure we position our portfolio strategically for the future.

While we already hold KLA Corporation, which we previously covered, we want to expand our knowledge and take it a step further. That’s why we plan to publish 1-2 more deep dives in 2025, covering other critical segments of the semiconductor supply chain.

In this write-up, we provide a comprehensive overview of AMD, exploring its business model, competitive positioning, growth prospects, and valuation.

Contents:

1. Key Facts

2. Business Overview

3. Management

4. Financial Analysis

5. Competitive Advantages, Opportunities and Risks

6. Valuation

7. Conclusion

Without further ado, let’s dive in.

Subscribe now

1. Key Facts

Description: Advanced Micro Devices (AMD) is a leading fabless semiconductor company that designs and sells high-performance semiconductor chips including among others central processing units (CPUs), graphics processing units (GPUs), field-programmable gate arrays (FPGAs) and adaptive system-on-chips (SoCs). AMD’s products power a wide range of applications including PCs, gaming consoles, data center servers and AI accelerators. Among others AMD competes with Intel in the CPU space and with Nvidia in the GPU space.

Key Financials: From FY15 to FY24, the company achieved a revenue Compound Annual Growth Rate (CAGR) of 23%, reaching $25.8 billion in FY24 while its operating income increased from a loss of $352 million in FY15 to $2.1 billion (8.1% operating margin) in FY24. AMD has debt and lease liabilities of $2.3 billion compared to cash and short-term investments of $5.1 billion.

Price & Market Cap (as of 19 February 2025): Its market cap is $186 billion with a 52-week low of $107 and a 52-week high of $227, whereas it currently trades at $114.7.

Valuation: It trades at a NTM EV/EBITDA of 23.2x (5 Year average of 29.4x) and a NTM EV/Sales of 5.8x (5 Year average of 7.5x).

2. Business Overview

a. History

AMD’s transformation over the past decade stands as one of the most remarkable turnaround stories in the semiconductor industry with its current CEO Lisa Su, playing a crucial role in its success. When she took the helm in 2014, AMD was struggling with declining revenue, burning cash, and losing market share to Intel and Nvidia.

By emphasizing on product-redesign, customer centricity and strategic partnerships, Lisa Su revitalized AMD. Under her leadership, the company’s stock price surged from the range of $2 in 2014 to $115 today, and in 2024, Time Magazine named her ‘CEO of the Year’.

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

The “Zen” Era

Recognizing that AMD needed a radical change, Lisa Su prioritized innovation over cost-cutting. Despite financial struggles, she remained committed to R&D investments, which ultimately led to the development of the Zen architecture, a game-changing CPU design that significantly improved AMD’s competitiveness against Intel. Zen introduced higher core counts and improved instructions per clock (IPC), allowing AMD to regain market share.

However, the true breakthrough came in 2019 with Zen 2, when AMD pioneered chiplet technology at scale. AMD was one of the first companies which adopted chiplet design at scale, extending the historical performance gains of Moore’s Law. Rather than relying on large, monolithic chips, AMD introduced a chiplet-based design, using multiple smaller dies interconnected via Infinity Fabric, the company’s proprietary high-speed interconnect.

This approach offered several advantages:

• Higher core counts with improved efficiency.

• Better manufacturing yields (a defect in one small die does not ruin the entire chip, unlike monolithic designs).

• Lower production costs, as smaller chiplets are easier to produce.

• Faster time-to-market for new products.

Subscribe now

Graphics and Heterogeneous Computing

AMD has significantly strengthened its GPU business with the development of its RDNA architecture in 2019, enhancing the competitiveness of Radeon GPUs against Nvidia. RDNA focused on performance and efficiency, delivering notable improvements in gaming and graphics workloads. While AMD still trails Nvidia in the high-end GPU segment, RDNA has narrowed the performance gap, making AMD a stronger contender in the consumer GPU market.

In addition, AMD has pushed into heterogeneous computing, integrating CPUs and GPUs into Accelerated Processing Units (APUs). APUs excel in power efficiency and affordability, making them particularly attractive for gaming and mainstream computing. The CPU handles general-purpose tasks, while the GPU excels at parallel processing, making it ideal for tasks like graphics rendering, video processing, and intensive computations.

An APUs improves performance by offloading certain tasks to the processor that's best suited for them, leading to lower power consumption. Additionally, they are cheaper for OEMs as the CPU and GPU are combined into a single die leading to lower manufacturing cost. However, for highly intensive workloads such as high end gaming and professional content creation such as CAD, separate CPU and a dedicated GPU might be a more efficient choice.

Strategic Partnerships

Lisa Su also prioritized key partnerships to solidify AMD’s market position. By working closely with hyperscalers (AWS, Microsoft, and Google), AMD expanded its cloud footprint:

• 2017 - Microsoft Azure became the first cloud provider to integrate EPYC processors (high performance CPUs).

• 2018 – AWS launched first-gen AMD EPYC processors for its cloud infrastructure.

Meanwhile, AMD is the exclusive supplier of semi-custom SoC (System on Chips) for Sony’s PlayStation 5 and Microsoft’s Xbox Series consoles. These partnerships ensured that for every console sold, AMD generated revenue.

Leveraging TSMC’s Process Node Leadership

Furthermore, at a time when Intel was struggling in transitioning from its 10nm to 7nm fabrication, AMD capitalized on its partnership with TSMC and leveraged TSMC’s 7nm process to develop its Zen 2 architecture. This move helped AMD surpass Intel in performance and efficiency, accelerating its market share gains.

Market share gains

Under her leadership, AMD transformed from a money-losing, declining company into a profitable industry leader with record-high revenues and market share. In fact, as of Q3’24, AMD captured 24.2% of the server CPU market, 28.7% of the desktop CPU market and 22.3% in the mobile CPU market.

Source: Digitimes

Read more

Our investment thesis was based on the following key points:

• Strategic Focus on HVAC: Carrier’s shift towards becoming a pure-play HVAC company promised margin expansion.

• Market Leadership: As the largest HVAC player in the U.S., Carrier’s scale is difficult to replicate.

• Favorable Market Dynamics: Industry growth supported by federal mandates, increasing environmental awareness, and incentives for energy-efficient HVAC systems.

• Viessmann Climate Solutions Acquisition: Positioned Carrier to capitalize on the growing demand for heat pumps in Europe.

For more insights on Carrier, check out our deep dive and investment thesis here.

Fast forward to today, Carrier’s stock trades 65% higher than our initial purchase price and at valuation multiples that now seem a bit stretched relative to historical averages. In light of this, we believe it’s time to reassess our thesis.

In this report, we provide an updated analysis of Carrier’s performance, a look at its industry dynamics, and a refreshed valuation to determine whether the company remains an attractive investment.

1. HVAC Strategic Transformation

2024 marked a transformative year for Carrier. The Company successfully divested all five businesses outside of HVAC and Transport Refrigeration, achieving $10 billion in gross proceeds. These divestments included:

• Fire and Security Segment: Access Solutions ($4.95B), Industrial Fire ($1.43B), and Commercial & Residential Fire ($3B).

• Commercial Refrigeration: ($775M).

Management executed these divestitures exceptionally well, both in terms of timing and maximizing value. As CEO David Gitlin stated:

“In terms of divestitures, some analysts modelled that we would yield $7 billion or so in gross proceeds over the course of 2 to 3 years. Thanks to the efforts of our corporate team, those in the businesses that have performed so well and our advisers, we reached agreements on all 5 deals in just over a year and will realize more than $10 billion in gross proceeds, which represents an aggregate EBITDA in the mid-teens.”

These strategic moves have significantly reshaped Carrier’s sales mix, with HVAC now accounting for 84% of total sales, up from 53% in 2020.

Source: Carrier Earnings Releases, FinChat.io (affiliate link with a 15% discount for StockOpine readers), StockOpine Analysis

The “new” Carrier projects approximately $22 billion in annual sales for FY24, with the following approximate breakdown:

• Global Commercial HVAC: $6 billion.

• Residential & Light Commercial (North America): $7 billion.

• Residential & Light Commercial (Europe): $4 billion.

• Residential & Light Commercial (Asia): $2 billion.

• Transport Refrigeration: $3 billion.

This more streamlined and focused Carrier is positioned in higher-growth segments, supported by multiyear secular tailwinds and a stronger margin profile.

Source: Carrier Q3’24 Presentation

Subscribe now

Strategic Priorities

Carrier’s focus for the next few years centers on execution and seizing growth opportunities in HVAC. Key priorities include:

1. Sustaining Double-Digit Aftermarket Growth: Leveraging its large installed base to drive recurring revenue.

2. Expanding Commercial HVAC Opportunities: Particularly in data centers, where Carrier has seen a 250% increase in orders year-to-date, and in mega-projects driven by factors such as reshoring initiatives, with recent example the semiconductor manufacturing facilities in U.S.

3. Transitioning to 454B Refrigerants: These higher-priced refrigerants are expected to boost the Residential and Light Commercial business in North America.

4. Revitalizing Viessmann Climate Solutions (VCS): After a temporary slowdown in demand for heat pumps and solar PV in Europe, Carrier aims to return VCS to growth as well as expanding its profit margins through synergies and organic revenue growth.

Management anticipates that these initiatives will drive 6-8% organic sales growth annually and 50 basis points of margin expansion per year, supported by productivity, higher mix of aftermarket sales as well as cost reductions in manufacturing, sourcing, and General & Administrative expenses.

2. Carrier’s Financial Performance: Growth Metrics and Profitability Trends

To assess Carrier’s recent performance, it’s more insightful to focus on organic revenue growth and adjusted operating margin, as total revenue growth and GAAP profitability have been distorted by the recent divestments and the VCS acquisition.

Source: Carrier Earnings Releases, StockOpine Analysis

Carrier’s organic revenue growth, which had been decelerating throughout FY23 mainly due to softness in North America Residential HVAC, bottomed in Q4’23. Since then, growth has rebounded, accelerating to 2% in Q1’24 and further to 4% in Q3’24. This improvement was driven by continued strength in Commercial HVAC, up nearly 20%, as well as double-digit growth in North America Residential HVAC. Organic growth was also supported by growth in total organic growth of orders both in Q2’24 and Q3’24, which spiked by 30% and 20% respectively.

It’s important to note that growth accelerated despite the headwinds in Residential and Light Commercial HVAC across Europe and China, which continue to show weakness.

In terms of profitability, Carrier has demonstrated consistent improvement in adjusted operating margin since Q2’23, with one exception: Q3’24, where adjusted operating margin declined by 40 basis points, primarily due to a 130 bps headwind from VCS. Despite this, year-to-date adjusted operating margin is up 120 bps, driven by organic growth, productivity improvements and a higher mix of HVAC and aftermarket sales.

For the full year, management expects the adjusted operating margin to reach 15.5%, representing 150 basis point improvement year-over-year.

Read more

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

Subscribe now

1. Key Facts

Description: Leslie’s (the “Company”) is the largest direct-to-consumer pool and spa care brand in the United States. They market and sell supplies and services for pools and spas, including chemicals, equipment, parts, cleaning accessories, and safety and recreational products. Leslie’s serves both residential and professional clients and sells its products through more than 1,000 physical locations as well as e-commerce platforms.

Key Financials: From FY18 to FY24, the company achieved a revenue Compound Annual Growth Rate (CAGR) of 6.9% while its operating income declined from $116 million (13% operating margin) to $67 million (operating margin of 5%). Leslie’s has debt and lease liabilities of $1.05 billion compared to cash and short-term investments of $109 million.

Price & Market Cap (as of 13 December 2024): Its market cap is $451 million with a 52-week low of $2.20 and a 52-week high of $8.21, whereas it currently trades at $2.44.

Valuation: It trades at a NTM EV/EBITDA of 11.1x (5 Year average of 15.3x) and a NTM EV/Sales of 1.0x (5 Year average of 2.6x).

2. Business Overview

a. Leslie’s history and reputation

Leslie’s was founded in 1963 by Phil Leslie, in a single location in Los Angeles. The Company quickly expanded to more locations to cater the growing demand for pool and spa care products, establishing itself as a trusted retailer in pool care. By the time it went public in 2020, Leslie’s managed to grow to a 1000 store chain across 37 states, making it the largest retailer in the pool care industry, capturing 15% market share in the lucrative aftermarket spend of the pool industry.

Why we like this industry? Pool aftermarket spend benefits from the growing installed base of pools and the recurring nature of maintenance and repair revenues, which contribute to consistent industry growth. Leslie’s estimates that more than 80% of Leslie's product sales are non-discretionary. Leslie’s history underscores the resilience of this business model. Throughout its history and up to its IPO in 2020, Leslie’s achieved 57 consecutive years of sales growth, a testament to the enduring demand for pool care products and services.

b. The IPO and the pandemic boom

Leslie’s went public in October 2020 at an IPO price of $17 per share, raising $510 million and debuting with a valuation of $3.84 billion. The timing couldn’t have been better as the pool market was thriving during the pandemic. With pandemic-related restrictions and lockdowns, people were spending significantly more time at home while also receiving government stimulus checks. This led to a rise in pool usage (more $ spent on pool care) and home improvement projects, including the installation of new pools and the renovation of existing ones. This drove increased demand for pool equipment, chemicals and hot tubs. In fact, construction of new pools during the pandemic, spiked to levels not seen before.

Source: Pool Corporation 10K filings, Pool Corporation Q3’24 Earnings call, StockOpine Analysis

On hindsight, this was the perfect time of a pool business IPO. Heavily burdened with $1.2 billion in debt at the time, Leslie’s used part of its net proceeds to repay $390 million in floating rate notes due in 2024, which carried a high interest rate of 9.5%. This reduced financial pressure, but as of October 2024, the company’s debt remains at $833 million - almost unchanged from its post-IPO levels (we’ll discuss this further in the financial analysis section).

Read more

Why? Weak China sales, sluggish travel retail recovery, compressed margins, repeated impairments, withdrawn guidance, and even a dividend cut. But is this the full story? Is the market overly pessimistic? Have Estée Lauder’s iconic brands truly lost value compared to a year ago?

As part of our ongoing search for companies with competitive advantages trading at compelling valuations, we decided to dig deeper. Does Estée Lauder now deserve a place in our portfolio? (You’ll find our conclusion at the end of this report).

Before we dive in, check out the deep dive we released last year, where we concluded: “While Estée Lauder remains a quality business with strong potential, we believe its current valuation does not provide sufficient margin of safety, especially considering the prevailing headwinds.” Give it a read, then fast forward to today’s article for a thorough update on the company.

Subscribe now

Contents:

1. Introduction

2. Performance Update

3. Industry

4. Valuation

5. Conclusion

But first, a word from our sponsor!! 👇

We want to share an earnings season tool that has become indispensable in our research routine: Borsa. Don't have time to read an entire earnings call transcript? Borsa's latest AI Summary feature makes catching up on earnings calls quicker and easier than ever. Borsa provides concise summaries of the opening remarks and the Q&A portion of every earnings call.

Borsa's AI Summary includes citations that link directly to the moment in the call where the topic was discussed, providing an interactive table of contents for every earnings call. Skip to specific discussions on operational metrics, market trends, guidance, etc. with just one click.

Borsa isn’t just simple—it’s a powerful tool for finance pros. With presentation slides, earnings releases, and transcripts for every call, Borsa makes researching companies incredibly easy. Don’t miss a beat—streamline your research with Borsa (iOS | Android).

1. Introduction

What does the company do?

The Estée Lauder Companies Inc. (ELC) is a global leader in beauty, specializing in the manufacture, marketing, and sale of skincare, makeup, fragrance, and hair care products. Its portfolio includes iconic brands such as Estée Lauder, Clinique, Origins, M·A·C, Bobbi Brown, La Mer, Le Labo, Aveda, Jo Malone London, TOM FORD, Too Faced, Dr.Jart+, and The Ordinary.

The company’s products are distributed through a variety of channels, including department stores, specialty multi-brand retailers, high-end perfumeries, pharmacies, salons, spas, freestanding stores, its own and authorized retailer websites, third-party online platforms, airport stores, and duty-free locations worldwide.

The stock: Estee Lauder’s market cap as of 25^th of November stands at $26.2B with a 52-week low of $62 and a 52-week high of $160, whereas it currently trades at $73 with year to date returns of -50%. Analysts have a 12-month target price of $80.5 representing an upside of 10%.

Valuation: Estee Lauder trades at a TTM EV/EBITDA ratio of 10.7x (5-Year average of 21.5x).

Source: Koyfin (20% off for StockOpine readers and 3 months free trial for annual premium members)

2. Performance Update

In this performance update, we will assess Estée Lauder's overall results, delve into segmental and regional performance, and highlight other key updates.

As shown in the chart below, the company demonstrated signs of recovery in March 2024 (Q3 FY24) and June 2024 (Q4 FY24), with organic growth rates of 6% and 8%, respectively (reported changes are shown in the chart). However, performance weakened in the most recent quarter, with sales declining by 4% and organic growth dropping by 5%.

The primary driver of this underperformance remains the ongoing challenges in China, including a slowdown in the prestige beauty market and persistently low conversion rates in Asia Travel Retail and Hong Kong SAR. Excluding these headwinds, the growth rate would have been a modest 1%. On a positive note, standout performances were observed in Japan and Priority Emerging Markets.

Source: FinChat.io (affiliate link with a 25% discount for StockOpine readers)

Profitability at Estee Lauder has also faced a downward trend in recent quarters, starting from Q3’FY23 (March 2023), with operating margins declining from approximately 16.5% in Q1&Q2’23 to 8.8% in Q4’FY24 and further dropping to just 3.9% in Q1’FY25. This deterioration can largely be attributed to sales deleverage stemming from challenges in Asia and Travel Retail.

As illustrated in the following charts, while selling, general, and administrative (SG&A) expenses have decreased at a CAGR of about 8% over the last three years, sales have contracted at a faster pace of 17%CAGR. Simultaneously, gross margins dropped significantly, from ~78% in December 2021 to 69% in March 2023, due to factors such as discounts and promotions, fixed cost deleverage, obsolescence charges, and a lower mix of skincare (the most profitable segment). This pressure on gross margins has meant that gross profit couldn’t cover expenses effectively.

Source: FinChat.io (affiliate link with a 25% discount for StockOpine readers)

However, a positive trend in gross margins emerged starting in Q2’FY24 (December 2023), where margins recovered to 73%. Further improvement is anticipated in Q2’FY25 (the next quarter). This recovery is supported by

Read more

It's been a year since our last in-depth coverage, where we focused on Alphabet's Cloud and YouTube segments. At that time, the stock was trading at $138 per share, compared to our valuation of $168. Since then, the stock has reached $180, marking a strong 30% gain.

Here’s the link to our full report for those interested in a deeper dive.

Subscribe now

Contents:

1. Introduction

2. Performance Update

3. Industry

4. Valuation

5. Conclusion

1. Introduction

The stock: Alphabet’s market cap as of 13^th of November stands at $2.2T with a 52-week low of $128 and a 52-week high of $192, whereas it currently trades at $180 with year to date returns of 28%. Analysts have a 12-month target price of $209 representing an upside of 16%.

Valuation: Alphabet trades at a TTM EV/EBITDA ratio of 16.8x (5-Year average of 17.6x) and a TTM Price / Earnings ratio of 24.0x (5-Year average of 27.0x).

Source: Koyfin (20% off for StockOpine readers and 3 months free trial for premium members)

Why Alphabet? Alphabet Inc. holds a commanding presence in tech, with Google Search leading digital advertising and YouTube dominating the streaming space. In cloud computing, Google Cloud is steadily gaining ground, riding the wave of global digital transformation. Alphabet also leverages its vast resources to pursue visionary bets, like Waymo’s pioneering work in autonomous vehicles, giving it an edge in shaping future industries.

1. Performance update

a. Overall Performance

Alphabet delivered a strong Q3 2024, with revenue climbing 15% year-over-year to $88.3 billion, led by solid growth across Google Services and Google Cloud. Additionally, YouTube hit a significant milestone, surpassing $50 billion in revenue over the past four quarters while the launch of Pixel 9 devices saw great demand. Alphabet’s ecosystem continues to demonstrate its vast reach, with Google Maps becoming the company’s seventh product to surpass 2 billion monthly active users. Meanwhile, Google Cloud continued to impress with a 35% YoY revenue increase, driven by high demand for AI-powered services.

This overall growth boosted Alphabet’s operating margin by 4.5 percentage points, reaching 32.3% compared to 27.8% a year ago, underscoring Alphabet’s earnings power and operating leverage inherent in its model.

Two years ago, CEO Sundar Pichai emphasized disciplined investments and efficiency. Since then, Alphabet has cut its workforce by 3% (from 187,000 to 181,000 employees), while revenue surged from $69 billion to $88.3 billion (a 28% increase), driving operating margins from 24.8% to 32.3%.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

b. Google Services

The Google Services segment, which includes both advertising revenue and income from subscriptions, platforms, and devices, generated $76.5 billion in Q3, making up 87% of Alphabet’s total revenue and reflecting a 12.5% year-over-year growth. Operating margin for this segment also rose significantly, increasing to 40.3% from 35.2% a year earlier.

Total advertising revenue, encompassing Google Search, YouTube, and Google Network, reached $65.9 billion (75% of total revenue), marking a 10.4% increase from the previous year. Growth was driven primarily by Search (up 12.2%) and YouTube Ads (up 12.2%), although Google Network revenue declined for the ninth consecutive quarter.

Despite Google’s dominance in digital ad spend, competition from Amazon and Meta is intensifying. For comparison, Amazon’s advertising revenue reached $14.3 billion, growing by 19%, while Meta’s advertising revenue stood at $39.9 billion, also up 19%.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

c. Google Search

Google Search revenue grew by 12.2% in Q3 2024, reaching $49.4 billion, demonstrating its resilience amid concerns over generative AI’s potential impact on search platforms. Despite these concerns, Google Search maintains a dominant 89.3% market share, slightly down from 91.6% in October 2023. In contrast, Microsoft Bing has made modest gains, increasing its market share to 4.15% from 3.1% in the same period, but Google continues to outperform Bing in search revenue growth over the past six quarters.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

Read more

Welcome to Part 2 of our deep dive into this hidden Mid-Cap gem. In Part 1 (Mid-Cap Marvel: High Margins and Exceptional ROIC), we explored how the company generates revenue, breaking down its journey from startup to industry leader by dissecting its operational segments.

In Part 2, we’ll evaluate the management team, which holds a solid 21.6% stake, indicating strong alignment with shareholders. We’ll also dive into the financials, which have shown impressive double-digit growth, analyze this fragmented industry, and assess the company’s competitive moat. Finally, we’ll share our valuation estimate and let you know if we’re buying now or holding off for a better price.

Last week, we kept the company’s name under wraps. Today, we’re excited to reveal it: ATOSS Software, a niche provider of workforce management solutions specializing in time and attendance, workforce scheduling, and resource planning. If you’re a free subscriber, you’ll get a preview of the ‘Management’ section. To go deeper into the financials and support our research, join our community for just $0.41 per day—two analysts doing the work for you at a fraction of the cost.

Subscribe now

Let’s dive in!

1. Management

a. Culture

To better assess ATOSS’s company culture, we initially used Glassdoor as a reference. However, the limited number of reviews there didn’t provide sufficient data for a reliable conclusion.

Source: Glassdoor

Shifting to Kununu (a German platform similar to Glassdoor), we found that ATOSS’s cultural ratings are around average (with the IT industry average at 4.0) and backed by a high percentage of employees recommending the company. ATOSS was also named a Top Kununu Company for the third year in a row, an award achieved by only 5% of employers. This, along with ATOSS’s Top Employer designation for the fourth consecutive year from the Top Employer Institute, gives us confidence in its cultural standing.

Source: Kununu

Additionally, ATOSS’s turnover rate has improved, dropping from 13% in 2022 to 12%, aligning with a healthy 90% retention rate.

b. Leadership

The Management Board at ATOSS is led by CEO and Founder Andreas Obereder, along with CFO Christof Leiber, who has been with the company for 25 years, and CTO for Product Management, Pritim Kumar Krishnamoorthy, who joined in 2020 and was appointed to the Board in July 2021. Pritim, a seasoned leader with nearly 20 years of experience at SAP, brought valuable expertise to ATOSS.

The remaining six management team members also bring extensive experience, with many serving over a decade at ATOSS, aside from the recently hired Chief People Officer, Thomas Wohlesser. Together, this seasoned team has been instrumental in driving ATOSS’s growth from a €20 million revenue company in 2006 to over €150 million in 2023.

c. Compensation

As we analyze a European company, note that its pay structure is relatively straightforward, with about 50% dedicated to short-term compensation. In 2023, the CFO’s fixed pay was 56%, while the CTO’s was 44%, whereas the CEO’s was notably higher at 85%. Over recent years, after adjusting for a €2.2 million one-time bonus awarded to the CFO in recognition of 24 years of shareholder value creation, the short-term component was 54% in 2022 and 51% in 2023.

The variable component (25%-50%) is divided as follows: short-term incentives (10-40%) based on revenue and EBIT, adjusted by strategic, non-financial, and ESG targets; multi-year incentives (10-40%) tied to qualitative goals; and restricted stock units (10-40%), with a five-year vesting period settled in cash. Overall, the compensation structure appears average, though the CEO’s pay ratio of 11:1 sits on the higher end relative to Adyen’s 7:1.

Source: Remuneration report 2023

d. Ownership

As outlined in Part 1’s ‘new chapter,’ AOB Invest GmbH, owned by Andreas F.J. Obereder (CEO and Founder), saw its shareholding decrease from around 50% in 2023 to 21.59%, while close family members collectively hold about 1%, per the 2023 annual report. Although insider ownership is down from last year, the stake remains significant, reflecting strong alignment with shareholders. Combined with a four-year commitment from the two largest shareholders, Andreas Obereder and General Atlantic, we believe management’s interests are closely aligned with those of shareholders, showing substantial ‘skin in the game’.

Read more

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

Subscribe now

In Part 1 of this article, we explore what the company does, where it operates, its solutions, future growth drivers, and its journey to becoming what it is today. Part 2, which will be released next Wednesday, will delve into its financials and outlook, evaluate the management team, analyze industry dynamics, and assess its competitive moat before concluding with our valuation estimate.

We chose to split this article into two parts because the Business Overview section turned out to be longer than anticipated, and we believe this undercovered company deserves a more detailed discussion. At the same time we want to ensure you’re not overwhelmed with information in a single report.

As a side note, since its IPO, the company has achieved an impressive +17% CAGR in shareholder returns, so let’s dive in.

Read more

If you're interested in learning more about Skyline Champion Corporation's business model, you can read our article, Skyline Champion Corporation – A Compelling Investment Opportunity, which we released in February 2023 (since then, the share price has increased by 39%). After that, check out the detailed update we published in September 2023, Skyline: On an acquisition spree. These resources will give you a solid understanding of the company before you dive in.

Subscribe now

Brief Overview:

• Champion Homes ("Champion", "Company") Overview

  Champion offers a leading portfolio of manufactured and modular homes, park model RVs, accessory dwelling units (ADUs), and modular buildings for the multi-family and hospitality sectors. It is the second-largest player in the industry, behind Clayton Homes, owned by Berkshire Hathaway. From FY15 to the trailing twelve months (TTM) ending Q1 FY25, Champion achieved a revenue Compound Annual Growth Rate (CAGR) of 12.5% and an operating income CAGR of 66.9%. The company’s TTM revenue reached $2.2 billion, with operating income of $171.4 million and an operating margin of 7.8%. Champion also has a strong balance sheet, with $549 million in cash and cash equivalents, and only $25 million in long-term debt.

• Key Investment thesis

  The company operates 43 manufacturing facilities across the U.S. and 5 in Canada, providing cost efficiencies through bulk purchasing and reduced transportation costs. It holds a dominant position with 29% of U.S. production facilities (43 out of 148) and maintains a strong presence in the HUD code homes wholesale market with a 19.9% share, slightly down from 20.4% in FY23 but still second in the market. Manufactured home sales in 2023, at 89,000 units, are well below the historical average of ~200,000 due to limited financing options and historically low interest rates favoring traditional homes. With a leading portfolio, recognized as the "Most Trusted Manufactured Home Builder" for four consecutive years and receiving top design honors, the company is well-positioned to benefit from industry tailwinds like growing demand for affordable housing, easing regulations, and improved financing options for manufactured homes, especially as current mortgage rates make borrowing for traditional homes significantly more expensive.

Contents:

1. Performance Update

2. Industry

3. Valuation

4. Conclusion

1. Performance update

a. Revenue

With sales starting to ramp up, Champion’s revenue in the most recent quarter ending June 2024 reached $628 million, up 35%. Of course this amount includes sales of Regional Homes, an acquisition which closed in Q2’24. Excluding Regional Homes, revenue increased 2.5%, reversing from a decline of 12.9% in Q4’24 and a decline of 24.5% in Q3’24. Therefore, Q1’25 marks the first quarter of revenue growth, signaling better times ahead, particularly as we are at the onset of the interest rate cut cycle in the U.S.

Source: Koyfin (affiliate link with a 20% discount; if you are a paid subscriber, you can benefit from a 3-month free trial) * Q3’24 to Q1’25 also include revenue from the acquisition of Regional Homes

Revenue growth was driven by strong growth in the US which was up 40% year over year (up 4.5% excluding Regional Homes) offset by softer demand in Canada; where revenues declined by 20.4% year over year as a result of economic uncertainty and higher interest rates persisting.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

On a sequential basis (Q3’24 to Q1’25 include the acquisition of Regional Homes US) revenue growth in US was up 18%, accelerating from 3% decline in Q4’24. Sequential growth in US was primarily driven by community and retail sales channels. In Canada, revenue declined 9% sequentially, an improvement compared to the 26% drop in Q4'24. Overall, the US, which accounts for 94% of total sales, is showing positive signs of accelerating revenue growth, while softened demand in Canada continues to impact the market.

b. Home Sales

Revenue was up as a result of growth in the number of houses sold which grew 33% year over year reaching 6,705 units. Growth was driven by US with homes sales up 36%, reaching 6,538 houses sold while average selling price was up by 3%, due higher mix of retail units sold.

Read more

Subscribe now

In this section, StockOpine dives into PayPal’s fundamentals, key financial metrics, and conclude with a valuation. If you’re interested in learning more about PayPal’s business model and competitive advantages, check out Part 1, prepared by our friend Timothy .

Subscribe to Panic Drop

Read Part 1 Here

1. Financials

a. Stock Performance

After a post-pandemic bust, this $80 billion market cap giant has been significantly underperforming the index. Despite being flat in the first half of the year, momentum has shifted since early August, with the stock now recording a ~27% YTD increase.

Source: Koyfin (affiliate link with a 20% discount), Note: Premium StockOpine members can get a 3-month free trial on the Koyfin platform

Let’s dive into the numbers to see if PayPal’s share price is reflecting its underlying financial performance and whether there’s potential for future gains.

b. Profit and Loss

Since FY14, PayPal has delivered impressive performance, growing its revenues more than 3x with a CAGR of 15.3%, reaching $31 billion. Operating income has also expanded at a 16.3% CAGR, pushing the operating margin from 15.85% in FY14 to 17.15% on a TTM basis. However, after hitting a 17% margin in FY21, margins dipped to 14.7% in FY22. Thanks to continuous cost discipline, they have steadily recovered.

A similar trend can be seen in net margin and free cash flow margin (adjusted for SBC).

Source: Koyfin (affiliate link with a 20% discount), StockOpine analysis

The key driver of margin recovery has been a reduction in non-transaction-related expenses, indicating that while competition may pressure transactional margins (which we will discuss shortly), PayPal has effectively managed its controllable costs.

Source: Company filings

c. Total Payment Volume

Payment companies typically perform well when more transactions are processed through their platforms, as they earn a percentage of each dollar processed. Growth in transaction volume can be driven by either an increase in users or by users transacting more frequently through PayPal’s platforms. During 2023, PayPal crossed the $1.5 trillion TPV mark and today has a TTM TPV of $1.6 trillion.

 Source: Company filings, StockOpine Analysis

As shown in the chart, PayPal’s transaction volume continues to grow, though at a slower pace compared to the pandemic boom of 2020 and 2021, when it surged by 31.5% and 33.1%, respectively, due to the shift toward online payments and reduced in-store activity. In 2022, volume growth decelerated as people returned to stores and competition intensified, putting pressure on branded total payment volume (TPV).

However, since the start of FY23, branded checkout, which accounts for about 30% of TPV, has shown healthy mid-single-digit growth, driven by improvements in user experience and bundling with unbranded processing (Braintree). Additionally, PayPal’s PSP (unbranded card processing) TPV—primarily Braintree's full-stack volume—also made up 30% of TPV at the beginning of 2023, posted impressive growth rates of over 25%, contributing to the reacceleration of TPV.

So, what makes Braintree (a competitor to the likes of Stripe and Adyen) a key driver for PayPal’s future growth? Let’s explore further!

Subscribe now

d. Braintree

Processing payments for large companies, SMBs, and marketplaces requires a trusted partner that delivers speed, minimizes fraud, optimizes authorization rates, improves conversion rates for merchants and offers a great user experience.

Braintree operates with lower transaction margins (due to lower take rates and higher transaction expenses, such as funding costs), but in the long term, it can become more profitable as marginal costs decrease with higher volumes.

Since PayPal began reporting PSP (unbranded card processing) TPV, we observe impressive growth rates. However, this has negatively impacted transaction take rates, causing concern among investors, who were put off by the decline without fully understanding the reasons behind it.

Source: Company filings, StockOpine Analysis

Investors fear (and some still do) that PayPal’s aggressive pricing strategies to gain market share will continue indefinitely, ignoring the fact that it takes two to tango. Price isn’t everything as value-added matters too.

Management has already indicated that the moderate growth of 19% seen in Q2’24 was due to a shift in discussions with merchants. The focus has moved from simply gaining market share at any cost to emphasizing value propositions and protecting margins. PayPal has now reached a point where it has a solid product offering and a strong market share, allowing it to prioritize sustainable growth over aggressive pricing.

“So let me take you back. Braintree, if you go back a few years ago, was really trying to establish itself in the market. It hasn't delivered at scale, and there were gaps in the product. We've invested heavily in the product and have really focused on some of the largest U.S. enterprise customers, which now have proven the scale while we've gotten the product to parity. Then you look at what we just rolled out with innovations like Fastlane, I think we've now leapfrogged the competition.

We now are shifting towards being able to have a price-to-value conversation with our merchants and being able to really start to think about how will we ramp up go to market for not only Braintree, but also PPCP. We also are now moving into markets that have higher margins. So international and small business with both Braintree and PPCP allow us to now, again, price to value and have different conversations. So that is how we think about it. We're not focused on unprofitable growth when it comes to Braintree.” Alex Chriss, CEO Q4’23

“I mean, this product, the Braintree product, in particular, has highest auth rates, highest availability, highest performance. It's really best-in-class compared to our peers out there.

“And so how we've entered this year is really working with our teams to say, profitable growth matters. We shifted our incentive structures, which are all around transaction margin dollars and operating income dollars now.”

Jamie Miller CFO June 2024 RBC call

Turning to the latest quarter, we finally saw Braintree positively impact transaction margin dollars.

“Braintree is now meaningfully contributing to transaction margin dollar growth for the first time in over 2 years.” Alex Chriss, CEO

With that said, we are confident that Braintree will remain a key growth driver.

e. Take rates

Beyond total payment volume (TPV), the take rate is a key factor for the revenue of payment companies. It reflects the percentage PayPal earns from each dollar processed on its platforms. Since losing eBay to Adyen in 2020, PayPal’s total take rates have dropped significantly, falling from 2.67% in 2018 and 2.5% in 2019 to around 2%. Transaction take rates have similarly declined, moving from 2.3%-2.4% to approximately 1.85%, and now closer to 1.7%.

Source: Company filings, StockOpine Analysis

Another contributor to the lower transaction take rates and higher transaction expense rates has been Braintree’s accelerated growth. However, we believe that as PayPal shifts its focus towards profitable growth, take rates should stabilize. Additionally, further efforts to monetize Venmo—PayPal’s under-monetized P2P app—could help boost take rates and protect transaction margins. So, what is Venmo, and where does the opportunity lie?

f. Venmo

Venmo’s digital wallet processed over $70 billion in the latest quarter, representing around 18% of PayPal's total TPV. Venmo currently boasts about 90 million accounts, with 62 million active users who transacted within the past month.

Based on our previous estimates and data from PayPal, Venmo's take rate is approximately 0.5%, which is well below the company’s overall average. This highlights why CEO Alex Chriss is committed to boosting Venmo’s monetization efforts.

Source: Company filings, StockOpine Analysis

While Venmo’s volume is growing at healthy high single-digit to low double-digit rates, its impact on revenue remains modest. However, PayPal’s “Pay with Venmo” campaigns, new partnerships with merchants like AliExpress, Venmo on eBay, Teen accounts, and Venmo debit/branded cards available in Apple and Google wallets signal promising potential for growth. An interesting statistic shared in Q4'23 and Q2'24 demonstrates this momentum.

In Q4'23, management emphasized the push to drive adoption of the Venmo debit card, noting that Venmo debit cardholders are among the most engaged users, generating 6x the incremental revenue compared to P2P-only customers. At that time, only about 6% of active Venmo users (say about 3.6 million) had a Venmo debit card. In the two following quarters, management reported a 21% and 30% increase in monthly active debit card users, suggesting that users could now exceed 4 million, with significant potential as the product reaches all 62 million active monthly users. This growth also aligns with PayPal’s omnichannel strategy (e.g., the PayPal Everywhere campaign) making Venmo an untapped growth engine for PayPal.

To conclude this section, here are two relevant quotes from Alex Chriss, PayPal’s CEO:

“What excites me most about Venmo is that we are only scratching the surface of its potential, starting to drive customer-led profitable innovation, and we see substantial headroom for growth. Said simply, Venmo is primed for growth.” Alex Chriss, CEO

“You've heard me talk about our Venmo customers looking for us to provide more money in and money out opportunities. As we are improving opportunities to spend Venmo balance with products like Venmo Debit Card or Pay with Venmo, we are seeing a corresponding improvement in funds being used within the Venmo ecosystem rather than transferred out. This is an example of meeting our customers where they are, solving their needs and driving monetization and margin improvement in the process.” Alex Chriss, CEO

Share

g. Transactions per active account

No matter how you slice the numbers, claiming that PayPal is in decline is simply incorrect. One main KPI we monitor to track the progress of our thesis is the number of payment transactions per active account (TPA), as it reveals a lot about user engagement.

Source: Company filings, StockOpine Analysis | Note: TPA ex PSP refers to the business excluding Braintree, providing insight into branded checkout and Venmo.

Similar to our earlier findings, TPA has been growing at double-digit rates. While PayPal has lost some users (active accounts—those that transacted in the past 12 months—peaked at 435 million in Q4'22 and are now at 429 million), each active user is performing more transactions. A further sign of improving engagement is the slight increase in monthly active users (those transacting within the past month), which grew from 221 million in Q4'22 to 222 million today.

Digging deeper into the data, we see that since Q3'23, TPA growth rates excluding PSP (primarily without Braintree) have been accelerating, reaching 6.2% in the last quarter. This demonstrates that growth is not only driven by Braintree but also by increased activity from Venmo and branded checkout users. We believe that a major catalyst for further acceleration in TPA could be Fastlane, which was discussed in detail by in Part 1.

h. Financial position and Capital Allocation

PayPal maintains a healthy balance sheet, with $18.3 billion in cash, cash equivalents, and investments compared to $12.2 billion in debt. At the same time, the company has been delivering value to shareholders through share buybacks.

As shown in the chart below, PayPal ramped up its share repurchases in 2023, buying back $5 billion worth of shares compared to $4.2 billion in 2021 and $3.4 billion in 2020. This was done during a period when the stock was trading at depressed levels (around $65). In 2024, PayPal continued this momentum, repurchasing approximately $3 billion worth of shares with a target to buy back $6 billion by year-end, aligning with expected free cash flows. This capital allocation strategy has reduced the total number of shares by about 11% since June 2022, and returns on capital have recently improved to above 10%, supported by the company’s enhanced profitability.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers)

Looking ahead, we expect returns on capital to continue improving as profitability increases and the company further reduces its share count given the $7.9 billion available for future repurchases.

2. Valuation

Having analyzed PayPal’s financials, we will now move into its valuation. First, we will do a Reverse DCF and discuss whether the growth implied in the current price is reasonable. Afterward, we’ll conduct a “sanity check” and conclude with our best estimate of the company’s fair value using a traditional DCF.

Subscribe now

a. Reverse DCF

In our Reverse DCF, we maintained the operating margin in line with PayPal’s TTM non-GAAP operating margin of 18%, applied a tax rate of 21% (consistent with its statutory tax rate), and used a 10% discount rate (our required rate of return) as fixed variables. Based on these inputs, we derived an implied 10-year revenue growth rate of 5.8%, which is embedded in the current price as of September 24th, 2024.

Is this reasonable?

Considering that analysts project a +7% revenue growth over the next three years and the Digital Payments market is expected to grow at a 9.5% CAGR from 2024 to 2028, we believe the market is pricing in higher risk for PayPal, likely due to competitive pressures within the fintech space. It appears that pessimism is baked into the current valuation, despite the company’s execution under its new CEO and potential growth levers. For context, PayPal achieved a 14% revenue CAGR between 2018 and 2023.

Source: StockOpine analysis, Note: If you want to learn more about Reverse DCF and to download a model you can do so here.

b. Sanity check

This is a simple exercise in which we divide the market cap of each comparable company (the list is not exhaustive) to assess the value the market assigns to each dollar processed. For private companies, we used their latest reported deal valuations (see links below).

It’s important to clarify that not all processed dollars are equal. For instance, a dollar processed through PayPal’s branded checkout (with a higher take rate) is significantly more valuable than one processed via Venmo or Braintree. However, this comparison provides useful insights into potential outliers.

In our view, Stripe stands out (potentially overvalued?) at 6.86x compared to Adyen’s 3.68x. If you are interested to learn more about Adyen, you can refer to Adyen: Simplifying Payments with Top-Notch Quality.

Source: StockOpine analysis, Revolut, Stripe Valued at $70 Billion

With that context in mind, let’s move on to our DCF analysis to estimate PayPal’s price.

Read more

Source: Koyfin (affiliate link with a 20% discount for StockOpine readers)

To get up to speed with its fundamentals, you can read our February article titled Rentokil Initial: Potential Opportunity in Pest Control. If you're short on time, this quote from CEO Andy Ransom highlights the company's future growth drivers:

“In Pest Control, we operate a simple, repeatable model in a global market that is underpinned by structural growth drivers, including urbanization, growing middle classes, population growth, climate change and increased regulatory pressure, particularly in food safety.”

Brief Overview: Rentokil Initial operates in 90 countries, with around 80% of its revenue from pest control services, while 61% is generated in North America. 74% of its pest control revenue comes from North America. The company offers a range of solutions, including rodent and insect management, wildlife control, and hygiene services such as washroom and clinical waste management. These services are recurring, with a customer retention rate of 82.3%, slightly below its historic average due to the Terminix acquisition in October 2022 but showing improvement.

Subscribe now

Source: Company filings, StockOpine analysis

Investment thesis: In October 2023, Rentokil's share price experienced a sharp decline following signs of softened demand in the US, its largest market. A second drop followed in September 2024, again driven by underperformance in North America. However, we believe this decline is excessive, as the market seems to be overlooking Rentokil's international expansion, underpenetrated opportunities, and synergies from the Terminix acquisition. While branch consolidation efforts are progressing, with minor disruptions due to the complexity of the acquisition, improvements in route density are evident. However, inefficiencies over July and August, caused by overtime work to secure extra business, led to cost overruns.

Does this break the thesis? Let’s dive in and update our valuation.

Contents:

1. Performance Update

2. Industry

3. Valuation

4. Conclusion

Subscribe now

1. Performance Update

We will break this section into 5 parts, namely North America, Profitability, International expansion, Acquisitions and Pest Control. But first, a snapshot on overall performance.

As of H1 2024, Rentokil’s TTM revenue reached £5.4 billion, growing at a 15.3% CAGR since 2018, with reported operating income at £642 million, reflecting a 19.1% CAGR.

Source: FinChat.io (affiliate link with a 15% discount for StockOpine readers) 

a. North America

Source: Company filings, StockOpine analysis

As evident from the chart above, organic growth rates in North America have trended downward, with 2.2% in Q3 2023 and 1.2% in Q4 2023. However, growth improved to 1.5% in Q1 2024 before slipping slightly in Q2, due to a drag in product distribution (despite a 50 bps improvement in Pest Control), resulting in a half-year organic growth rate of 1.3%. This stabilization at such low levels, especially when Rollins, its closest competitor, achieved +7% organic growth over the last four quarters, explains why the market is penalizing the company. Management has acknowledged its struggles in attracting and closing deals, and is now focused on addressing these weaknesses.

Read more